Gene list
Applied filters:
COG category: Intracellular trafficking and secretion
Gene type: CDS
Gene type: CDS
Gene type: CDS
Genomic element: chromosome
Number of genes found: 150
Show UniProt / TrEMBL protein name | View in Fasta format (DNA) | View as list | ||||
# Yersinia pestis CO92, CO92 >YPO0263 type III secretion system apparatus lipoprotein MKSLRQMLAIVLMTLSLSGCDMELYSGLSEGEANQMLALLMLHQINAEKQ IEKSGMVGLTVDKRQFINAVELLRQNGFPRQRFITVDELFPANQLVTSPT QEQAKMVFLKEQQLENMLSHMDGVIHADVTVAMPMSVDGKNPLPHTASVF IKYSPEVNLQSYQSQIKGLVRDAVPGIDYAKISVVMQPANYRFSASEAEQ QQGPQTTVQWLLRHVGMVQNMVGVAFISLIVLMFVGWFYYRRR >YPO1710 putative fimbrial protein MSAYFYRVKTVIRHINMYLRVYAHVRSVATLLILVVVAGGPSSKVWAEGL GINCDYTGSIYINPPTSIIRVKPNAAIGDPIGSWMTISAPEVWSCALLPA YQSRDVRAGILVFSPYNPLLTTNIDGGNYKVFRTGDTNPGLGIAVRFRAI GAGFSSDWTQLEGFGLVDGTVSAPLIGPIPYNDGIKFPLGMEMQIHYVKA SEELRSGGVRIFDFAYLYHRRSIDGVPDNSGARYRIVQVPANSIDIQIMT QTCTTPDVVVNLPEVNSRQFTGIGTVKALKAFNLNFNHCPGGLDGINYKF GATTSILDSANGVVALDANSTAEGVGVLLRSQSDAAIELDKEYTMSGYDT SSTQSYTVPMQAGIYQIENTVTPGSVKGEFTFTLIYK >YPO0690 putative type II secretion protein MIVPLKIQELMRERMLANIDINKVELLVGDRNKLIGLLSQTFDDLFNNNE YNLTTQAQKYIIEMIADEITGFGPLRELMEDDSISDIMVNGPERIFIERY GLLKLTDRRFVNNTQLTDIAKRLMQKVNRRIDEGRPLADARLIDGSRINV AISPIALDGTALSIRKFSKNKRRLEDLVDMGAMSSDMANFLIIAASCRVN IIISGGTGSGKTTLLNALSKYISEDERVITLEDAAELNLEQPHVVRMETR LAGLENTGQITMRDLVINSLRMRPDRIIIGECRGEETFEMLQAMNTGHNG SMSTLHANTPRDAVARLESMIMMGPVNMPLITIRRNIASAINLIVQVSRM NDGSRKIRNISEIMGMEGEHVVLQDIFTFQPASTRDDQGRIQGEFINHGL FNRSSVRINADIHNLANELNSVFSTVSK >YPO0810 general secretion pathway protein J MIKRPDCGFTLLEMLLAVVIFSMISFIIYSSLRVTIKSNNIMGNKVQELI RLHRVISLLERDISHSVMYIGSQNDYFSNEGRIIGIGVLDSDSFGIYMLR NNKINTEIFIHYQHERLGYRLKKNCLERLSYLILKNTNKIETKFSCLIEG INDFRVRIFHQGKWLNEWSRIDLSPQGIEIILDVKGVGVIRRFILLLH >YPO1921 probable pili assembly chaperone MILIARQIIACSMLLLTSVSLSVQASVVMTGTRIIYPEGSREKVLQLSNK DDHPNLVQLWMDDGNNQSSPSKSDVPFALTPQIFRMEANSGQVVRLTYIA RNLPKNRESVFYLNFLQIPALKADTLGEKISVTLDTTTGNKIKVHNPTGY YISLRDAKIVSNGKTVSFATSEMFAPDSTTDLALPIGIKAKKGELLILNV VNDYGATIPNNYYL >YPO0587 putative autotransporter protein MKNSNRSPKNISRNFKHHKETSLSSKNKSPIATCVAAALFIFGSSSVIAN PDHEGIVVGKSILNKKQSAVNAIINEGNSLVLTDSASAEHTAVNTGSIFT LKEDSTADITSVTGGFFSLSGSSKANINTVLSGGWLEVNDDASITETTIS SDIEKKSTVRLYQDGSATKTTVGDNGILYVSGDSRAEETHVTKGGKLIVY SESQGPTLKNTQIAGTLTLKSDVTLEGKTEFVSSATIKTTGHLIDNQGQL IFNSDKDIVIEAMIDGQGSLTKENPLTTLTLSSAGDAWVASYVYSGETHI NAGNLKLANTHFFGSPISGNPNTRLILEKSTLDTTVQGSSVFIDKHSIWN MLGDSNIHHLDILDSGRHDLNNPGKTGNQLIINGDYFSDNGTLIFHSQLA GDDSVTDHILIKGNTGGHTNVRVINVNGEGNKTDSGIQLIEVRGISDGEF SQVGRITAGAYEYRLGRGKDELSKNWYLSSDITDYSSDGVPEAELPGILV LKSDNAAVFSAKLADYALQAVGGVVDSFTQPETSPPSNTPELTVPDPKRA NAAAFSAKLADYALQTVGGVVDSFTQPETSPPSNTPELTVPDPKRANAEA FSAKLADYALQAVGGVVDTFTSPEQTEQTTATPDSTPKSTDSAVKPASTP KPTDLAVKPANTVISNAKTAAPKRQTLVHTPENGSYIANIAMARNLFTTR LEDRTSHYLYKDIVTGQWQPTSMWMHTQGGRSQFGHTVEQLNIKGNYYSV QLGGDIAQWATNEQGSGRIGMLAGLGKATNHSHSKVTSYHSRGAVDGYNL GIYATWFADQQHNTGVYIDTLAQYSWFNNAVNGQDKAEEKYKSSGFTTSI ESGYTFNLANSDQLSYFIQPNAQITWAGINAQTHKTADGAVVSYRNNGHF ITRIGAKAYLQTHDTLNTKFTPFVAVNWIHQNQNTGTTISGQGIDNKIQN STEFNVGVESQIDQQLHIWANINHQIGRYNYTDTNALVGVKYHF >YPO2945 frimbrial protein MRKLNLAVCAVALSVISSTSYAAAGGTVTFNGKLIADTCQVDTASENITV TLPTLSIQSLAVAEAQDGSKDFEIKVLDCPATLTQVGAHFNAIDSSGVNP ATGNLVNKAPTDAAGNVEVRLYNVDDSSQIRVGSTGNMVNIVKVGATPGT ANLTYAGGYYATDATTPGEVNAKVEYVLAYN >YPO0689 hypothetical protein MIYYVVALSGILLLVLNNLKWMKIKRSISNTKKSKAKSTSSITILIKKIF FEWIDYVSTHSKSTPHILLPICSLVIVYYINSTWINVNYSFVFIINIIFI IVLQLKYARSKHYLLFKQDFPEVLLMINMAASSGASINQVLERCGKEIRG PLGQELGLICRRLNLGETPETVFYDAYERFHYPEFYFLVTIILLNIQQGG QLKELITRLSQIITKKKTTEQKKAVMTAQIRMSVNIISIMPMLFSFLLYL LDPTTIEFVWQHPTGRFIIYYIIISEVIGILIIRKMLGKSL >YPO0687 hypothetical protein MMIFLLSGCLSQQGLSSQGLSTKEFSYRESILIKANNQIGLIKLYRESLK NKEDESIRVKLANAYYLSGDSHSSLYYLQPISHKPNVSIYLLQIKNLINE GDNSGATTVLHRLLSIAPHNPEAHNLKGIILANRGDTAGARTAIVQSQAL FIQEDIARNNIAVISMLDNRYEDAVKILLPDYLSGKRNNLILHNLVFALI KMGDTRYAKNIIEAERLSDNADELVLALSQVDSFPQEQSFIREK >YPO0302 putative outer membrane fimbrial usher protein MVARCINLQCIAFLFSFFPTLAFPVTEEGEVVFDIETLERLGYSAELAKF FSGQDRFLPGQHDVTIIINASKTYRIAATFDSEGKLCMDKALLMALKLRN TESDGSCENMEARWPGMVVKLFPGQFRVEITLPQEAFDPEMEGSEYQQGG HALLLNYNIFGQRVESNNSRFNLVQGQFEPGINFKNWVLRNRGSYSYNQG VSQYYNQETSALRAVESLKSVVQLGEFGLVGNTFSGLPVTGIQLYSDNAQ RDDTQLIVPIEGIANTNATIEIRQRGRVIYRTIVAPGPFSLSNISNFSSG VNTDVSIIEEDGTQQNFTVTSALDINAEQQASIYQLAVGRYRDMFTGEDR PSPLLLSGEMSFNPAATFYMTSAGLLSSGYQNIRVQNLYSGWDQAWFSAA ASYANTKDAGQGYQFSVQNQMTINGNFGVSWSSVYGSANYWLPDDALSSS NNLNDLMFGKLKNATSVAVSWVHPRWGAFSYALSNNMYYQASGRTYHIFS ISEQFGRATTILSSQLSSQGQNSLYVGINMPLGNGTLSGRVQRNNGNVAL GSTYQGRWGDNKDYSVGISGDNRQRRINGSMNIRTAYSQLTGGVSQATNN SRSAYLSSRGSVAYVNNTFATSSSSVGDTFAVVNIPNQPGLRVSSPSSGI AITDYAGIALLPLVRPYTASKVQISTQTLPLNIRLNNTSADLLMTRGSVA THHFETTETRQLLLTIRGSDGEMLPIGANVLDEKGNFLGTIIGDGNFMLE NKAIGVTLRVKANNRDECRVNYREPEKFDPDVLYEVADAVCQ >YPO0243 hypothetical protein MLAAELWLRMTQVKGLGVVKRSALAKRLLASGDIHPGRLAAYGLDSQQCH QFAQLSPRYIADTLEWLSDPNHHLLTYGEPGYPPRLVHIAGAPLVLFVSG ELDVLYRPQIAMVGSRHFSHYGEQWGRYFASELARTGLVITSGLAVGIDG ICHQAALNIQGRTIAVLGSGLENIYPQRHSRLAKEIEYQGGALVSEFLTT ALPIAAHFPRRNRIISGLSDAVLVVEATLKSGSLITARYAMDQGRDVFAL PGPLGSASSEGTHWLIQQGAYLATSVKDVSEQVSGSLQWLSLPEEVIISS PQEQVELPFADVLANVGDEVTPVDVVAERAGQPVQDIASKLLELELAGWI AAVPGGYVRIRRAGHVRRSNLLI >YPO0902 putative surface protein (partial) MNNADDQSCYAIMDGPSVGPITSPNCNTPSIGIINTNAGQLFVGGTGAAV SGTLGPTFWTGTFATPVGTSNTATAYGMVVQSGGAYITGNTYVQGGLFLN GQKATNLAPATISSTSTDAVVGSQLYNLVQDGTRYFHANSVNPTDSLASG LETIAVGPATVVSGDNGVGIGNTALVGAAATGGIAIGFGTQVTAAGATAI GSAAQAQGAQSLALGAGAVTSQANSIALGAASINTVGAQSSYSAYALTAP QASVGELGIGTALGNRKITGVAAGSASSDAVNVAQLTAVGDQVQQNTANI TSLGGRVTTIEGSMASIANGGGVKYFHANSTQPDSVASGTNSVAIGPASL ASGNAALASGAGAVAIGDGAAASADGSVAIGQGSGDNGRGVENYIGKYSN ASNTSSGTVSVGNTATGETRTVSNVADGLQATDAVNLRQLDGIAASIVVV ENNVSGLQNGTDGMFQVNNSSGLAKPSATGANSATGGAGSVASGNNSTAF GSGAKATAANSAALGANSVADRANSVSVGSVGNERQITNVAPATQGTDAV NFDQLKSISNQTNAYTNQRYSELKQDLRKQNSVLSAGIASAMSMASLTQP YTSGSSMTTIGAASYRGQSALSLGVSSISDSGRWVSKLQASSNTQGDFGI GVGVGYQW >YPO2044 putative hemolysin activator protein MLWQMNIFFRKKYMIILLLSNAVLATENNKNRLNDNVVSHADIDVRNEYN EEGNRVGKRFFSTNHHSVASQKKISPEKICLPITGVFLQGNTLLSSQDLN QIDHILGECISEDDINILAKEVTRLYLSKGYLAARVNFIPLNNAGELGLN VTEGIVEKIEGGGRRVNPYFIFPNFIDKPLRLSELDQAIDQANRLRSNKV NVDILPGSQAGKSIIRINNVNNKPWSLSTVIDNYGYKNSDEWQARVSLAL DSPFGLSDSINFNANRTLENAKNRYKNDFTVSYSVPYGALTFSALANYLE YRRYEKLKNGTVNFNGNSQQYNFRTDYMFHRTQKQINSLSMQVEHKQINN YVDEAKVGVYSYRFTNLELGVNQFRILPHGSVNVNAAIKRGVPWFGTHQK NKINAVQFTTGKLMVNFNHNFSLLNSPYQFDHALVGQYSKNYAPSPEWIS LTERNAIRGFSRSSQSADHGWYMKNTLSKHFFMGNILFTPRMGVDGGRAL KHGSQQGWQSNAGVSAGISMRYHQALFDVEASRGWWLSDSNKQNEPVQVL GRIAYTF >YPO1697 putative chaperone protein MIKYHLLSKLILSFILLPIAPLHAAVSVLIWPIDPVINDDENATALWLEN KDSQPTYMQIRVLSWRQVNGLDDYNAQTAIIASPPVANIQPGKRQLIRLV KNAQVPAGKELAYRILIDEIPRQEPNDKNNPSSTQLGLTFQMRYSVPLFV YGNGMQIAPEATQPTDIAQPTLSYILNRQQGKQWLTIRNQSEIHARISQV TLNGQTVNNGLLGYVLARSQMSFPISLAARKGELAAIINSNTKPVTIPYQ >YPO1672 hypothetical protein MLKHFRLGLFTANVQADTGSQHSFSRVPAAAINPITLAIVVAFSTIALPP MALAACTSPGVGTYVCEGENTDGIILSGTDIAVETQPGFSIIVPENGDPA LSLVGSGTISYLDTNSSALDTTGADSLYIQNDTHTTGQSSSINVQTNGSM GSGINISNHSGADSTVQVDVSGTLFGDLNGSPALLIYSSAENNSTILMNI NTIFGDVGIRSDNTSFNGTAITNVDIANDINATYSGATINNSGSGGTSVV NFNSKSIITELDALNIYNTNYSGAVITNVDIDGDVISTTSQATSFYNDAY NGSANFTFRANNVTGEYSGISINNSSHNSANNNHDNAVITDILLTGDLTS TSGSGLQINSYMDDGDIKVSAQLENIYSYYEALSVRADTLTGNLQFNIDV SGNIVAENGLGFMVMGGASEGNSTMIINANNISSGSQALNIYNYSGLGSA FTAVTATGHLVSEQGIGAMFSTYVSQGDATAVINLNDITTAGSGVKIDTI ANGGNSTTYLTVVGQINSSLYDGIDLRATATEGNTLVSIDVNNIASEYDA IHLDNKNYTTGADNGTSTIDLITRGALVSQQGYGINIETNTADTYVTVGG LVHGGNGTAIGIHRLDNIQTSATLELQSGYALEGVTQALVFNGSYAEIND AALDLANSHLVLGGAGDAAFDLTRIDNREEAILDGDPNRIIGFGTLTKTN NSIWTLTGANMADGDANAFLSANIAGGILVLDNATLGLTPDAGALTGATV NRLSAADIAADPTLVATETGALTLAEGGALSSLGDSVLSGNLISAGGILL SNHYTGGNGAATDDRLTVTGTYFGENNGSGEGAWLALDTVLGDDDSATDR LVINGDATGTTSVRVNNAGGLGDKTLNGINLITVDGLAQDDTFLLAGDYV TTDGYQAVVGGAYAYTLQADGEAATAGRNWYLSSELMLTEGVRYQAGVPL YEQYPQVLAALNTLPTLQQRVGNRYGAPGALADLDFDNNQWAWGRIEGSH QVTDPARSTSGSQREIDVWKLQTGIDVPLYQSQDGSLLTGGVNFSYGKAK ADIHSFFGDGRINSAGYGLGTSLTWYGNNGVYVDGQLQTMWFDSDLSSRT AGHAVASGNNGRGYTSAIEAGKGYALGNGLSLTPQMQVTYSRVDFDTFRD PFDSEVSLQEGDSLRGRIGVSLDKETTWSAKDGTTRRSHIYSHLDLHNEF LNGSKVQVSGVEFATRDERQSVGLGAGGTYEWQNGRYAVYGNVNLLGATR NVSDNYAVGGTIGARVSW >YPO3823 putative lipoprotein MYKKIVRFLAVGLLVAGLSACDNSSDNNVGQTVSLLDGKVTFNLPADLSD QSGKMGNQANNMHVYANNTGDKAVIVILGEGTNEKLEVLTNRLAEQQRAR DANLQVVTNKTININGQPFQQLDSIITSSGQKAYSSIVMGTVGNQLMTLQ ITLPAENQQQAQTEAESIISTLKLK >YPO1920 probable fimbrial usher protein MRIAPWLSCLLTQSLLVTHISSAADNNNQDDYIFDDALVRGSSLGLGSIA RFNKKNSYDAGQYQVDMYMNNKFVDRLKMLFVDKDNSVEPCLSVAQLLQA GVKEEALKTADPKTPCLAFQSILPASDFRFDHAKLRFDLSIPQKFVKNVP RGYVDPKNLTAGNTIGFSNYNLNQYHVDYNKEGIKRTTNSTYLSLNSGIN IGMWRFRQQGSLRYDASRGTNWTSNRLYSQRALPTIGSEITLGETFSSGQ FFSSLGFLGVALSTDDRMLPESQRGYAPVVRGIARTNARVMVYQNNRSIY QTTVSPGAFEFNDLSVTHFGGDLTVEINEADGSVSTFQVPFASVPESLRP GYSRYSFAAGQVRDVGNNETFSELTYQQGISNAITANTGIRLASGYQAIM LGGVFTHYIGALGLNTTYSHARLPDGEQQQGWMAKASFSRTFQPTNTTLS VAGYRYSTDGYRDLSDVLGVRATSNDSSWNSSTYRQRSRAEISLNQNFHR YGSLYLTASSQDYRDDRSRDSQLQLGYSNTFWRNTSFNLAISQQKTGGAN KIYFVDPGSGMPASNGANTLATRETVAQMSISFPLGGSSSAPYVSAGAVN SRTSGASYQTSLSGTMGSDQTAGYSVDVARNEPTNENTLSGSLQKQLPTT SLSGSASRSPGYWQGSASARGSVAFHRGGVTLGPYLSDTFALIEAKGASG AKVMYGQGARIDRFGYALVPTLTPYRYNTLSLDPDGMDFNTELQDGERQI APYAGSTVKVTFRTLNGYPALITIKMPDGSQLPMGTVVYNYNGKGTNDKN DIVGMVGQSSQAYLRAEELSGTLTLVWGESSKERCQLDYDLGKPTDNDKQ LYKLDALCVAVQQ >YPO2482 hypothetical protein MPPLRSTRGKTVQGTQLDGAVIGSTATADKNTLDTGTLGFSDIDNQADFK VEHQSVGISTGGNIGSQFVGNMANGLLVGANNEGHADSTTHAAVSEGMRA ALLDIRVFMMSIYGVFYQSVEDIDFFIRETKEFSFPEDYQVPEHYNYRRE >YPO2045 putative hemolysin MKINKFKLSPAGKLTVILSLILTPITNSYSAEIEAAGNTYMRGNEHIPSV YNNPDGVSVINIAPPSEHGLSHNQYMEFHVNEHGVVFNNSLERVVKNGLT YDANLNLRGSPARVILNEVVGPNASVLAGHQDIVGIPADYILANANGISC QGCSFAPEFKNVTLAVGKVVTVRGDLRSIDTIGNANLLNVSNDRDDNNMA DALTLIAPVISTNGHIKVKGDADFVVGQNMYHFMKDKTPEVEAGNSKIKT IDGYYLGSISANRINLVDTREDNNINLFGDVTAEETKVVTSGTLRLRAAE DGRQDITIKNGMNISANKIDTTREFTADEVKLFDIKENKVNKTIINAGRI DFVAVEDVKLAGTTILSNDDLSITAKSLHVDSHLIKHSQDTGVVVTHVNI LDAPTKKVEIKNNDHVSQASAIMSRKNVKLHGQDGLELKNANIQAYGNIK LSSEGDIHLNGSTETNTTINNITYINYDEDLKRGHNNVETVTERFAPLDM KARGNIDIQSKNTHIHGAKIASEGELSIDAKGDVYIGLASMLTSEFKDID YNMWGGAHGSEKDKIEEYVYTGNKSDLVGGRVKITAGNDARILGGKINGV DSGEISAQNYLSIDGVLGTRSFKRDQKTGGIMHTNESASTSQNHYEKFID SEISSDGDFRIFSQKDLYIDGSRINVNGKLDINANEKLTVQAARQQQKID EEKTRLSIEWFAKESSDKQYRAGILINHQKDTENTLRDEHQIATLSAEQI NITAGDDIKFFGTGISTSKGDVIIKTPKNVGFFTAKNRALINKNQVNNSG GFYFTSGMDKTGNGLQYTHIDKESYSDIENNLVVKTHIKGDLNINAGGDL NQQGTQHDVAKNYSVEASNINNMASNNLAFSKTDTLQVDVSIGNNIDHSG MTRPIEKVIKDPANTLDYIGGRGSQKGVSDPTIGLDVDVSGSRTKTSDND ALALVTSIKAQDIKQVAKKDVLDEGTQYHATEGGMSLQGARHFSRAAVNS KANTTEQEKGEVSLRGGMTATQEIKGHLGVKAETSQGDSYAEEMLVGNIN AKSGVSIKTTGDAYYYATNIEGGNGDITIDAGNNLYFDQVQDSQRSSNIK FSGHGKLSLGGSSGSKEFRLEGGGGYQQGRSQRTDAIVSKINTQGNVTLK AGADLTTKGMQIGKQGTRASDVSLLAAGEVKLLAAVSGSADINDSALADF RLGGKRATGGASKEGFVGAGVQADKVNQSVSDRQGGHIYSKNTVSIKSDS DSNQAIHLEGLKIDAPKVDLSAQQGGVFIESALSELPKDNWNFGFNLDMV LKNTSPKKEDGTIDKDKASESHYKGAGIKVMVDKQDMFKHQNAHINTAYF SLNTKKDAVMKGARIESTRADVNVGRDLTIESLKSKEDSVKVDVELSLSH TNDKSSSVTSKLSKVTLKKFEKRTQEKLDSGIKDIGLMYNNKVKPKDTMG GVGFSKESQGVYLPTLSSETKSRNFADKTARYLGGQLKGIASGPEGLDGR AKLDVQIVNNDAVAEQSGIFGIDETNISVKGTTKLHGAEISSGSGQLTLE TENRELSNIKNSTHKGGVGLMFLLVY >YPO0940 hypothetical protein MFSRIKAKRIDLENPDLASDGFNKQDFANKVAASVDHNASDLHLCTGFHP VLRIDGELKTFTDWPKVTAGWLNGLRRHMLSDAQESRLQQQGQVDCAYTT VGSQRLRANIFQQRQGQSIAFRIIPAICPSLTQLAAPPILNQLIQQDNGL ILVTGATGSGKSTTLSAMISAINQQQARHIITLEDPIEFIHSSQSCLIQQ RELGRHTHCFSRALNGALRQDPDIILLGELRDLETIRLALTAAETGHLVL ATLHTRTATQAIDRLIDVFPPEEKAVIRTQLAASLRGVITQKLCRQNGGG RIAVFEILTQTTAVSHLIREGKTYQLPTVIQAGGQWGMQTFEQSIAQRQK QGVLAINH >YPO1708 putative chaperone protein MRRTLLTILSFLRTVRLLTTLTLLILSVVATVARAEVMISGTRVIYEEKQ REGVVKVSNTGDMPVLLQAWIDKGDANARPEAIKVPFSVTPPVVRLDPKR DQTIRLFRTDGGLAADRETLFWFNLLEVPPKPIQSAAGGENKMQLAFRTR IKMFYRPEGLTVLPAQAAKSLAFSMKGNQIVIKNASPYYITLRKLELRTS EKGPVLANFTKINNKMVAPFSELSLPTSAKASINNSAQVFYSVINDQGGE TQGTQKLTQ >YPO2881 putative fimbrial biogenesis protein MKLTKLWRVCLVVSVLTGCSGTPPENTSQAVAGQTRLQLGLAYLAQGDLT AARKNLEKAVEADPQDYRTQLGMAFYAQRIGENSAAEQRYQQAMKLAPGN GTVLNNYGAFLCSLGQYVSAQQQFSAAALLPDYGQVADSLENAGYCFLRA NQDKQARVLLSRALKYDPDKGEPLLAEAQRHFGEGNRAQAQLLLDVYQHT LPASAESLWLQIRFAALAGRQDSVQRYGKQLARSFPQSKQYQHFLANEY >YPO0273 putative type III secretion apparatus protein MSTEKNEKPTPKRLKEAKEKGQVVKSVEITSGVQLVALVIYFLLTGYSLV EQAKALIRSSIIQLQQPLTLALARIGAECMTVLMHIVVVLGGALIVVTII AGIAQVGPLLATKAVSFKGERINPIQNAKQLFSLRSVFELMKSLLKVGVL TLIFGYLLMQYAPSFGYLTHCGSRCALPVFSTLMGWLLGSLIACYLVFSL MDYAFQRYTIMKQLKMSHDEVKREYKDSNGDPHIKQKRRQLQHEVQSGSF ATNVRRSTAVVRNPTHFAVCLIYHPEETPLPIVIEKGHDEQAALIVSLAE QSGIPVVENIALARALHRDVACGDTIPEQFFEPVAALLRMALELDYQPSS DDPPR >YPO1696 probable outer membrane usher protein MIIRFRLPPLSVLIYGSILLPSLIPLTILGGSLPPPSTSTTMPDTTLYLE LVVNDRNFGSTVPISYRNNRYYLSQSQLRTIGLPISEPLAPEIAIDNMAG VNVKYDGENQRLLINVPSEWLPKQQIEVTEQDDFNLAQSSLGALFNYDIY ATQGYPYSSLTHFSAWTEQRIFDRFGLLSNTGVYRTHFPSNNNTDDAKGY IRFDTQWQKNDEEHLLRYSTGDLITGALPWSSAIRLGGIQIARHFAIRPD LITYPLPQFSGQAAVPSTVDLYIDNFRTQSANINPGPFVINNAPRINGAG QATIVTTDALGRQISTSVPFYVASTLLKPGVWDFSLSGGALRRNYAIRSA DYGEMVASGVVRYGTTPWLTLEGRGDIAKEMHVIGGGVNFRMGLLGVLNS AYSISNTSNGAFNNVAEPLNTNNATPNRLPSPAASRRGRGNQRSLGYSYS NAFFNLNAQHIISSDEYSDLANYKTPSLLSRRMTQLTGSLSLGSYGTVGS GYFDVRDALGEQTRLINISYSTSLLRNSNFYSALNRELGRKGYNVQLVWS IPLGPRGSSSISATRTNDNQWIQQLNYSRSAPSNGGLGWNLAYANSTNNN NQYQQADIVWRTSMMESRMGLYGNSNNYNYWGGLTGSLVVMNRSVYASNM INDAFALVSTNGFSNIPVSYENQLIGTTNAKGYLLIPTVASYYQAKFQID PMNLPADVMLPNVERRLAIGERSGYLINFPIKRISAVNIRITDASGQDLP KGSAIYTTGNIPISYVGWDGMVYIEQVAQLNNLRIIRADNGTQCYSQFKL KTTEGIQDAGTTVCR >YPO0150 putative membrane transport protein MQALADYRQLNLITTTGVGGNLSLRLIEVPWEQALAIILRMGRLKAEREG TVMMVFTEQEIQERQQRTKQQAAPEALANLTLALQYANAEQVADSLDPLQ GGLLSPLGSVVADKRTNTLLIRDTPASLALLKNWLIEMDLPLQQVQLSAH IVTISSEDLQELGVRWGMGEGKGNTALRINDFNVNLPLPNSAASVGFHVA RIGGRLLELELSALEQENQVDIIASPRLITSHQQTASIKQGSDIPYTVSR GKKEAAAIEFKEAVLGMEVTPKILRNGKIILDLKISQNMPGITIKRGESE MLLIDKQEIKTQVTVNDGETIVLGGIFQQKKRQSVNKVPLLADIPLLGAM FRQDTQQQSRRELVIFITPKLISA >YPO0684 hypothetical protein MQKKTMITFILEKYEFFIKNRQGAILLSFMALIPVFIGLIFLSFEFSHFI QKRAKLSDALEQASLALSTENNYRNDRASNNRNNYLVTSYAQSYLPSERF SQPRVVNTYNESLGYTEYNASLQMNYQLALLNSYLKQTPSPTWDVNENGA ARKYLSSIAEPIDVVFVTDFSGSMDLPFGDIERNNRITKLDELKAIFVKL NNRIFSNDGINTIGFVPFSWGTKRISANGQVSSTYCHFPYSPKKIDGNGH YLQRYTASNLKNIPGLDNLSGIDNLAYGQLDEDKHHAILSEIEKKHRDNE IPTKTRDQAKNFLDKAYKVNQISTITKIVEEHIDYKETINSIDRNGETID IPMDDILDPFFCLKETNAKSLNFDPNSKGDINEILNMKAEGGTLASSGIL VGNKMLTESQNNNKLMIILSDGDDNTQKMSSPHDQKAGIINITQKLITEG MCQKIKDNGIKMVFIGIGYVPDNNIIDWEKDCVGTGNFYLAKNAHELEIS IERALVVDDEVGRNIPKS >YPO4044 fimbrial protein MSNVKKSTFIIALATLSVIYQALAADAGNGRIKFTGTVINAPCSIALDST DINVDLGQVANRVLETGNKYSQSVRYNINLQDCSLTAQGSGGATYPALSK VNVTFSGIADAAAPALLANTGSAKGVGVRLIGTDDALLKVGDTSPDINLT SGPNQIVFSARIEATSAPVTTGTVVSQATYALNYK >YPO0683 ExbD/TolR-family transport protein MAMRMNDSLDESGELHEINVTPFIDVMLVLLIIFMVAAPLATVDIKVDLP ASSAVPQPRPEKPVFLTVKADNQLYVGDQPVDRETLATALDKVTQSNKET TIFFQADKVVDYETLMSVMDALRKSGYLKVGLVGMEAGSSGAK >YPO0271 putative type III secretion apparatus protein MNNHMSSYHENAIIVHLATELLWLVLLLSLPVVVVASTVGLVISLVQALT QIQDQTLQFLIKLLAVSATLLMTYHWMGATLLNYTQQSFLQITSMRP >YPO1922 fimbrial protein MKKTLVTLMLFILPGIAFAETSNNTIKFQGEVAEQTCMVDINGTANTPVV LLPTVSTSNLNQVNSVAGKTNFTINLTGCNIAIQDTQISSVFQGMNVTSG GNLGNIGTARNVAIQLIDPRGTPIRMSGGSVEVPGITLATGATSASQDLS AQYITEEGQATAGSVIASAQYAITYP >YPO0700 Fimbrial protein MKKNIFLTLRSERYKAGLLLLLLLLLCTTSKPSFAALQVNSCSLAVSGAG GETPFVIKALPVTLTNGFVLGSMNFSVVTTFTKTGTTADYLYLGGWSMLA GGAVMPVSTGVPGVKMSVNVSDALFGGYEWGNTEKATQSLFVPGTKITIA NRVTVQLIVTDASVYQGGVINWFNVARSFALVSGNAQVWSTKSVATGGSR CGDMVTFNIGSTNIVLPPPTVATCDLGATDIVVALDPIDTSSLQTQGDRA GGQAFSIPLGSCAKDAKPYITFTDSSNKANRTNILSLSPSSTATGVGLVL EKSDGNLVTFGAENASVSASNVGQFLIGTSTAAGGSMPLNLTARYIRAEG VLKSGNVKADAIFTVAYP >YPO0599 putative adhesin MNKNLYRIVFNQARGMLMVVADIAASGRAASSPSSGVGHTQRRRVSALSP LSFRLLIALGCISLSAQAAIVADGSAPGNQQPTIISSANGTPQVNIQTPS SGGVSRNAYRQFDVDNRGVILNNGRGVNQTQIAGLVDGNPWLARGEASVI LNEVNSRDPSQLNGYIEVAGRKAQVVIANPAGITCEGCGFINANRATLTT GQAQLNNGQLTGYDVERGEIVIQGKGLDSRGQDHTDLIARSVKVNAGIWA NELNITTGRNQVDAAHQNINTNAADGRHRPAVAVDVANLGGMYAGKIRLI GTETGVGVHNAGEIGASAGDIVITADGMLVNRGQISSAQQLAVNTPSGIE NSGVLYGKGNTQLTTAGKLSNSGTVAAAGDTLIRAAEVNSSRNSVLGAGI KSDNSAITRGTLDIKARGQLTAQGKNISGTAQTFNANRIDLSGSQTQSGD LTFTTEGGDIDLTGANLFANRRLSVSTPSLLRTDKANLFAEQIALDAQAL ANVGGVITQTGLTDFNLNLPGDIDNRDGTLLTRGNFLLQAEHLTSNSQSL LGAGIQSDGKLAPRGDLNVTTRHALIAQGKTLTAGTLALSGSRLDLTDSL TQAKYMRLTATEGDIALTGATVMAANTLFADTRQILRSDKAYLTADQINL TAYSLSNVEGRVVQKGSGDFRLDLPGYLDNRGGVLLTKGNLALQAERLTS NSQSLLGAGIQADGSKASKGDLQANTTQALIAQGQNVAAGTMTLSGSRVD LTGSQTHASNITITARDGDVTTREATLITPGTLSMTAVANPEQTLNNRGG KLHADNIQLNLAKLENSNGEIAAATDLWLRLQSDFIHQAGARLTAGRDLL FNSRGALINQYKLEAGRDMQLTALSIRNTSADRNTNADNSSLLAGRGLSL STDSLFNRGAIYTTGVGQFTVNGNTENIGEIYTEQQLTFTATGNLANRGV MQTRGEMQLSAQGDVNNSGMLYSAGDQMRLSIAGNLTNEGKLHVANGEMR LLTEGNLDNRGSLYGAGNSDITTQGNAVNTGSVYTQGALQWLTKGSVRNS ASIAALGDLQLRANDLLSDNQSLMAAGLKADGSRSDSGNLAVSTEQALIA QGQNIAAGSLALAGSQIDLTGSQTQANAISLTAKSGDITLTSAVIKAATQ LLVTQLAATRSSFIPPSSIPPSSTQSSSTQASASPSAWLRTDKASLIADQ LTFDVQALSNLGGVIAQTGATDFNLNLPGYLDNRGGTILSKGNVAIQAQG LDSDSGSLLGAGVQSDGKLTNAGDLAVTVRQDLIAHGQSLAAGAMTLTGS GVDLTGSQTQARGITITANKGDVSTQRANILSLGSLAINAGANAGQTLNN QGGSLQANNIALNLGQLDNRTGKIAASQDLVLGLQSDFNILADSTLQAGR DFSFTTHGALTNDGQLLAGRKLSTRSNSLLNNGNIRAVQADLRASGALTN RGEILTRGGLSTDANTLFNSGTLIGATATLNARERITNSGPNALIGATDK NGTLALLAPVIENSDTVTRTDTAPTTTLLGMGKVILAGGQDNSGNYSSAA QVLNLSGLIESGNDLLVYAKTLTNRRQILTATTDFIVGDTETGAAYWTAE NPDIPGGRYTQPPAGGPMNSDYIGTNYTSTVAYNRIDQISPEAQLLAGGN LTLQVGTLENNWSKVSAQGVIDLTGVTLQQDDWGSQQRLVEQTTSSGEYR YRTYKGKLWGIAWGPEMKLRLNNQYASSITAKTLTGSGTVINNTVINNGA APGAIVAPRDRDSTGKNIAVEFNGIALTLPRSGLYQLKTDKGDYAPGPEA ALSLANISPPSSLDATGPRGVPPPSDDLNRTGLVTPDRAVSGGYLVETHP AFASLNNWKGSDLYLQQLSSDPSVIHKRLGDNAYEQRLLRDQVLALTGRT VASDYRSEQAQFEQLFAAGVQYSKAFNLAPGTRLSAEQMATLTGNIVLME NRDVAGQTVLVPVVYLAGVKPGDLRANGALIAAENISLTEVQGFANAGAI SASNNLQISMAKDITLNNRCGLLQAGNHLQLSTLNSDIDLTSARLNATNL QLDSGRDVILRTASDQYSSGNGAVQRTQTILGPLASLNISNNAVITAQRD FIQQGAGINIGKDLQVNTGGDWLLSTVQRSDQISAQYGGGSATSGSLRHL GSEVKVGGALSANVDNLTAVGARVNAGTIDVRAQNITLSAATDSLSVTGG SSSKRHTSSVNLYDETLLGSQLNATGDINLQTVNDITLSASAVQTDGALK LAAGGDVTLTSQTEQHDEQRNHTGTKKGLLSSTTTRSEEGRSQTLAVGSM LSAGSIDVSSQNIAVAGSSVVADKDIRLRAQENLTVSTAQQSESGSQLFE QKKSGLMSTGGIGVFIGTSRQKTTDQTQTVSHVGSTVGSLTGNVRLEAGN QLTLHGSDVVAGKDLALTGADVAISAAENSRSQQYTAESKQRGLTVALSG PVGSAVNTAVTTAKAAREENTGRLAGLQGVKAALSGVQAVQAGQLVQAQG GGITEMVGVSVSLGSQKSSSQQQQEQTQVSGSALTAGNNLSIKASGSDIL IAGSQLKAGGDTRLDAARDVQLLGAANRQKTDGSNSSRGGSVGVSVGGSG LSVFANANKGQGNERGDGTFWTETTVDSGGMFSLRSGRDTALTGAQVSAE TVKADVGRNLTLQSQQDRDNYDAKQSRASGGISVPVAGGGAAVNLSMSRD RLSSQYDSVQAQTGIFAGSGGVDIRVGEHTQLDGAVIASTAAADKNTLDT GTLGFSDIKNKAVFTVEHQGGSLSTGGPVGSDLLSNLGGMVLAGLGNGGY AEGTTQAAVSEGTITVRDTENQQQNVDDLSRDTGNANGSIGPIFDKEKEQ NRLKEVQLIGEIGGQALDIASTQGKIIATHAANDKMKAVKPEDIAAAEKQ WEKAHPGKAATAEDINQQIYQTAYNQAFNESGFGTGGPVQRGMQAATAAV QGLAGGNMGAALTGASAPYLAGVIKQSTGDNPAANTMAHAVLGAVTAYAS GNNALAGAAGAATAELMAPTIISALGWDKNTLTEGQKQAVSALSTLAAGL AGGLTGDSTADALAGGQAGKNAVENNLLGGNEFTHTQFVQKHGADVLSCA DNPSNAACQRGIAENKAYIAALATGSVALLPGSSQAMWALGAGTNAGMQY ADNGKINPVNSVAAGWINVITMGQGWKGTIAWNAAGGALINAINGGDPLT GAITNGTGAGFGYGVGNYVVKPAANTLGKWITGGWNPKFDPNLLKYAEVK GQLGISKEMLPSKIPSAVGNAGGSLSSEFGSSLIQQKKDAMEDSK >YPO3028 putative autotransporter MNTNSKKTYLNIAISFILYASTAMNANADSCIDYTVTDICEQSKYAAGEF HNIKLGDGVTAGSEDHHFVFNGEGYELYNSNANFSAQIASGTIRYTEVNN SYFTVNAHHFPDDTIYAGRAENTTLNDSLMWVATSADQTLAKGNSMVVVS TQMAMVDQIFVTTLNDGSLPFDPVITNSRYEDTSYEMLWGMKNEAKGWDT KATSHDSVFVDASKQSIEANGHSIGATFYGRATQVVKAGGESQDTHLFDH SYSWVYAEAKLTGLTEVNDAATVYLNAAATQGAYAENVVLNGEDTTLMVR ASLDNNAYATVDNLILNGGEVVFQQSSGDQYASLNIGTLSGSGSFLFNTS IAEGKGNFVTIANASGEHKVIVNDSGHEITSPDMTTLDLIHDLSGDATFT LASISGANIIEVDGGTYVYSLNTWDNSARAGGNLWYLGSGLNTGTELEPE PEEKTTPSTDAVLSMASSNQFIFDGEMQNLRFRKGDLNNNKGDGASVWGR YLTNNTRVNAAHDAAYRLQQDGFEIGADKVLEMSSGQLVLGGFTSYSNNR VKHARGGNSTVDSYSLGAYGTYFDNSGYYVDAVVKANRFKNSLNAHMTNG GSVQSDYNQNAIGGSLEAGYHYSLSNNWFVEPYVRTSYYTAQDKDIALNN GMTANIDNNRSAKGEIGTHLGTKIDLNNGAIIRPYAKVAIEREFIKSNTV TINQVNDFNNDLSGHTAKYGLGMDINLMKQTSVYAEANYRNGTHVESPIM ANIGFRINF >YPO2491 putative hemolysin activator protein MRYCYFILHTAILFPLLVISRAGQSAELTPIQQQTLHQQERQRALEERLA PPTPDVRLSAPSASSDRLIFPVEKPCFVIDRVTLSGTEPLPRWLPLQRIA NQALGQCLGGQGINQLMSQLQNRLVGHGYVTTRVLAPQQDLNSGTLALQV VPGKIHRVALTPESDRHVTLFSAFPARPGHLLDLRDIEQGLENLQRIPTV QASMELIPGSAPGETDIALSWKQSKMWRLAASLDDSGTRSTGRYQGGATL FLDNPFSLSDQFYVSAGGSIKNRGDKGTNNLTGHYSLPFGYWTAGITASS YDYHQTVAGLNSDYNYRGESENVSLQLSRLLHRNASQKTTLTYDVLTRSS KNYINDTEVEVQRRRTSAWRIGLQHRHFISQATLDAGVSYQRGTRWFGAV PAQEEYFDEGTALSKILQLNAQLDIPFSVMAQNFHYNVQYQRQSSSTPLT PQDQFSIGGRWSVRGFNGERTLSADRGWTVRNDLGWYTPIQGQEIYVGLD YGEVGGRGSAYLLGNHLAGAAVGIRGNVLNTRYDLFAGKPLSEPDGFQSD AVTVGFNLNWQY >YPO2542 hypothetical protein MWVLPINSNPTVLHPPMVDRVYIDRQIDELELYFCPDTGKCKKLTTEMRV RNEIYKNLDYFYYFLEKSYTSVALSLLIVEQAWTNTHQPVSRGNIKPEYR LDDYRRESLCEFAIREILKTVDEAIISQPSTTDSFTKKKNKKAYEDIISM VSYLVGLTKDKIQGAKQRYGSDPITQVLFQEFNKRNIFHDYSGNEQDVLK DAMNGIVYSCYKFYSEKEKLPSVDVIKKIMKEVPQSINYPDSETAAYRLI SKAIIDPMIIDINYEKHCHLSHLNALARTLIAKDIPITHNRKYKHYLTDN LNNKFIRLFLLDKTFDIRKSELYQRVEQHLREINENISADDILRCCKDYY EFAREKYALKIPSLAEVEFTEQLTRSGHISAAIEHRRHGTYLPRTV >YPO0303 putative fimbrial chaperone MQNFPTHHRDIGATIIYVNSVNRFNIFFVFTLLILLSSWSAVSYASFKLE STTVILQESEARTSFTIDNISSNPILLVTKLTDLDGKSFSKQILISPPVT RINAGQSQQVNFVLKKGSVLNNEVLLKASFEGVEQVPGNAAVMPIRQEIG FLIQPSAVPQIRMPWQTLVFSISGNNLVIKNPGKHVVRLGPQIILVPSNE VVALGNPYIMPETSKLFPITSSPTAVKVTPLSRYGFVQTEVTLPVTR >YPO3950 hypothetical protein MIAATVLLFLIMDPLGNLPIFMSVLKHLEPKRRRVVLIRELLIALILMLI FLFAGEKILLFLNLRTETVSISGGIILFLIAIRMIFPSSESNVTGLSAGE EPFLVPLAIPLVAGPSILATLMLLSHQYPNQLSHLVLALMIAWGLSAAIL LMSNLFLRLLGSKGVSALERLMGLILVMLSTQMFLDGVRAYLAI >YPO1387 hypothetical protein MFTKSNFKKSVVIITAIFSGSVFADVNIGDFNTGVIGNGTAVGNNNSLGG STNGVVVGNGGSLSNSINGVVIGNGSVSDGDGVSVGGGTSTNGGIAIGSG SNATRSDEMNIGDRQITGVKAGVADTDAANVGQLVAKAGETLNSANIYVD NQATETLNNANIYTDNKATETINNANTYTDNKSSETLNSANSYTDNKSSE TLNSANTYTDSKTAEIFNTTKTYMDGKSKETLNNTYDYVDSKVSSIVYDV NSYTDKTVNTAFETSLSDAKSYVDDKYNQLSDKVNKNFNKTNAGISGAMA MSGIPQKFGYEKSFGMAIGAYRGQSALAVGGDWNINHKTITRVNVSADTE GGVGVAAGFAFGIN >YPO1711 putative chaperone protein MKTLWLILRPRARKVNNLRTLLITAILSSLVLSATVQAGVAIGLTRVIVT GADKSGSVQILNDGLHPALLQLWVDNNIAEMDKPIEQINVPFVVDSPVFR LNAKTNKSIRIYYTGGANQLPSDRESMFWLNVLEVPPKASANQSSQNAVQ IAFRSRIKLFYRPAGIPISSEGVATKLSFTLVPKGEGRVLRVANPTPFNV TFQTLAIAQSHTAQGVTIKLGADDMVGPKSSVDSAPVGNNALAKNMSVFF TIIDDFGSPIEGQQPLQ >YPO0808 general secretion pathway protein L MKLTFTLLIRLGETEFEPIYWYVESQGKKLVRHGKINGVAELKNITLYAN NVVKILVPANKIIFRSLSIKKNEVMNNIKSIAFSIEQSISSDIDNFHIVI LDQDKDFCHVAAIEHELMNRWLFWLNINGISACCIMPDAFALPFFNSEWS VIKIESNWLVRNNEMSGFLVNSSVLENILMLAEPTIKVNTFSPTDIKWGN WQSLDYSDPVLIMAKTVSGNHVNLLSGKYKYAERIIVNNSVFLRVASWFF LLFLVMSLNGWYQGYKIVRDTGALSKVAQDFYADFLPPAYHGGDVNTSFN KYISDLDLKKNNVSFIKLLNAVSYYTADENVDVRSFNFNYSDGEISFDIE GDDDLINEMLNDKTNLFNARVEVIRSGEDKYNIKLSSQP >YPO0688 hypothetical protein MRIIFFTLLILLGLIIILKVNSRSRRISVYNKINSRENKSKEANNDTKDK PTVLSDFIKLPVFLSNILYLKVLIVIFILSILTILAIFNVVNINQKTLLT IGLLSIISTLYLPRMIIKNALTKRTNNLLKSLPFFIDITAACVQSGMTIE NSLNYTTQKFQTINTDLCLIMSKVTKRAEINGLENAIKELQYYSPAIEMK MFCSTLQYSISFGSTVYEQLTHLSQDMREMQLLMTEESISKLSTKLTLPL FLFILIPFVLLVISPSILELLNYVKNI >YPO0695 hypothetical protein MDVIRLSLIVLIVSQLLFVCYSDIRHRIISNKFIISISFNAIIFSLVMHH TVSIIIPIVALFIGYIIFHFNVMGGGDVKLITVLLLALTAEQSLNFIIYT AVMGGVVMVVGLLINRVDIQKRGVPYAVAITAGFLSSVLI >YPO3878 putative fimbrial chaperone MLSIYARHYHYLFVTLLVAMSLSFANASVVMTGSRIIYPAAASEHSIQLT NNDNFPNAVQVWLDSGDEKSTPETGKAPFIVTPPFFRIEANSGQTLRLKY TGSGLPTDRESVFYLNFLQIPPVNKVEKDNKMLVLLRNRIKVFYRPESII GRVDQVSTALTFSLRKQGTNLVLTGKNPTGFYATIASGEIVSGSIKLKVK SNMIAPMSQVEWVIPNASVSSSATINFLIMNDFGGQDAGSYRI >YPO0266 secretion system apparatus protein MSKSALVRGLTMITARQDIFLAVMLLVAVFMMILPLPTTMVDLLIAINLA FSVILLMISIYLRDPLEFSVFPSLLLITTLYRLALTISTTRLVLLQHDAG EIVEAFGQFVVGGNLAVGMIIFTIITVVQFIVITKGSERVAEVSARFSLD GMPGKQMSIDGDMRAGAIDSVEAKRLRERVQKESRLFGAMDGAMKFVKGD AIAGIIVILINIIGGITIGVMQHKMSAEEAMNTYAVLSIGDGLCAQIPSL LISITAGIIVTRVPGSNKQSLANELAVQVGRQPDALWLAAAILTVFALLP GFPFLIFITLAAAVAAPAFLLYRKNRRISQDGRANGGSEEGGATGQRMTP GAVPLMLHCASNLHHPHLGRDIDGLRWRWFEHLGVPLPEVEIRCDPTLAE NTLSVQVYQERVLEVVLPPDSLLLTRPCSSLVTNNQVLGAKMGSFDWLDA KQAMQARTLGIPYVEGHQRIITCLTRVFERYTAEFIGVQETRYLMDAMEG RYGELVKELQRQIPVGKVAEILQRLVEENISIRDLRTIFGALVVWAPKEK DIVMLTEYVRIALRRHLCRRFSHNKTWISVLRLGDGVEHLIRDSIRQTSS GTYSALEERQSLLILNKIKNAFAENQDAVLLTTLDVRRFVRKIIERDLFV LPVLSWQELGDEMNLKVAGTIELIGDELDETA >YPO1388 hypothetical protein MNKEIKRMQRMQCIYIATWLIAVFTSPIVIANNTNINGSTNNNGNGTINI FDASSNNDIHTLTGLGNEQLGGFSNHLIDSHNNTIDGGQSNNLVSSDGNM ISAISLGDGLFYGAQNNTLINSNNNLLIVTQGSTIIDSDSNTVSGISNNL IESNSNIIGNENSCYSDPASPSGAWCVDNQNTLIGSDNNTITGALNGLHN SHNNDIIASSVNNLMDTHNNIIAGGHYNTISGGGNNDIFGSENNVTDSTD ANINGSNNYVIDGNGIGRDDLTEDNSILGGSGNMGVGDSVTAITNSVVFG GNTSGNSTGSTLTDSVSVSGNGTSGNNVVNIGGAANGNNSASLGTGSVSS EGGIALGSGSIATRNDELNIGDRQITSVKKGVENTDTINVSQLNDSFDDV LNLSNEYSDNSFSTVTENINNYTDASLDTVLNTTGEYTDNSILLVTNESN NYTDNGMESVSNYANIYADESLLAIYNEEANYMSNLIDVTLNNANNYTDL SVNTIIYTGKQYTDSRINEYQRTFKNEFLTYSNGKFGGFDKDINQKQKQL NAGIAATMAAAVIPQKSGSKVSIGVGLAGYSDQGAGSVGAIWHVNQRITM NTTMTYDTQRGVSLLTGLSIGI >YPO0816 general secretion pathway protein D MYISGKGIKSIHGMIFLFTLIMPLDIISANFSVSFKDVDIKEFINSVSKN INKTIIIDPTVQGLISIRSYENLDKDTYYQLFLNVLDVYGYAAIEMPHNV LKVISSKRAKGVVAPLPKEGVTFDGDELINRVIPLRYISAKKITPLLRQL NDNTESGSIINYDPSNILLITGRAAVVNHLHSIVTDLDQAGDNEIELYKL NYAIAADVVKIVNEAINPINNLKQEVSIVGKVIADERTNSILISGDTYIR KKSILMIKKLDKRQSSDGNTKVVYMKYAQASKLLDVLNGISEGFHNEKKT KQSNQWNQRPVAIKAYDQTNALVITADPDMMLALGEVIEKLDIRRAQVLV EAIIVETQNGEGINLGVKWENKRSDDINFIKNSDGLLNNNGWGIATTITG LTAGFYKGNWDVLLSALSTNTNNNILATPSIVTLDNMEAEFNVGQEVPVL ISTQTTTTDKVYNSISRQSIGVMLKVKPQINKGDSVLLEIRQEVSSIADS STVNTHNLGSVFNKRVVNNAVLVKSGETVVVGGLLDKKSSTIVNKVPFLG DLPLIGWLFRQTKEKVEKSNLILFIKPTILRESDDYSVVTSKEYNKYKKD NMNGYTLADDIVLSDKKYLSVIPSIRKDINNFYTLLDSEL >YPO4005 putative hemolysin activator protein MIFKINVRWRDKIGDFWWGILCLLYLQIMIGMLPFKVFAEMALPEMDLLE MDIAEPQIPNSIIPPLSHAQLASEPVLPENLYNDEVQCVAINNVELINLD AFPNAAHLKEKAEEAHGRCLGEQGLSVLVANLQQQLVVDGYITSRVVFVD DSERDGTLMLKLMPGRIEDIRHHQDSVGNAHLSSLFPGKRGDLVNLRHLE QGLENLQRLPSVNATLDVELNRDDLSSQIIVNRQQSRLWRINAYLDDAGH DAVGRYRTGLILSFDNPLSRYNPLSLSDLLYFSVNRDLDSQPDKGHNSYG VHYSVPYGNWLFSMTGNQGERYQSFSFAGKRLAGKKFGYRSHWSVLDTQI QHLLTRGVNYKTVGYAGVLIRQSASFWTHREIDIQRFNTTDWQLGIEHLH YMPWATFRGGVRYQQGASWFGAQPIPGKMSTAPARLVDITSSLDIPFKIG TQSFQYRPAFSQQHTYSDISSLDKFTIGGRSSVRGFNENNALTGSRGWSL KNDISWISPIPGQTFVGQQFYIGMDYGEVSEQGQPFLLGERLAGAVVGTR GNYHAFGYDFNVGVPITKPAEFDADPLVFGFTLTWQY >YPO0269 type III secretion protein MIGSGRQTAGVSVALTEIDGEGVYLPLHYGGQECGLWLSQSCWQHWLNTT LATDNPQLLAAELVIAMANWAVTPLLALFTDLVVLAESPQKRSLPKQWAV TVAFELEGQPIIGVLQDWPQAALADTLSHWPCEAVTAPDLLWQSGLVAGW CHLSLRQLQQLRPGEGLRLSMAAELDKEACWLWHHASPQIYIKLEGGNRM TIQQINEASDPLACGSRAESPPLAAVQLEDLPQTLVMEIGRLTLPLGEIK QLAVGQTLACQTHCYGEVNICLNGQSVGRGSLLRCDEKLVVRIAQWGLQN GENIME >YPO1709 putative outer membrane usher protein MLSAFIFFQKNECLKYLPAFSFAICGIGGMLYIPSSAAENSEYVEFSDAF LRFPVDATRYSEGNPVSPGERQVDIYLNDQWIGRQEMRFALPSPESKVAT PCFDVKLFDELGVDTAKLSSDTVKLLESRGACSPLSRLLEGGNAIFDDNQ QRLDIQVPQAYLIRQARGYVHPKYWDDGVTAATLKYDYTGYRSNQNDIGS QTYQYLGLLGGLNWQSWRLYYRSALNRSDSQGFDYQNLATYVERAVPSLY SKMTIGDSNTDGQVFDSLSYRGIELTSDDRMYADSQRGYAPVVRGVARTN ARVVVRQQGRPIYETTVPPGPFVIDDLYPTGQGGNLNVTITEADGSEQTF IVPFASIAELLRPGTTRYSLMAGEYRDNSMVDKPVLFMGTVRHGLSNLLT GNGGMVAAEGYLSASAGLAFNTPVGAVAFNVTQAQTRLPNKDNQRGQSIG MTYAKSLPETNTNLTIASYHYSSNGFYTPAEAMRMRDYLQHGEVNNTQID SSWPNGSDRYDDSFKYRRRNQAQVSIAQGLPDGYGSFYANANVQDYWDGR NRDMNFQFGYTNSYKSLSYNVALNRLRDIPSGDWDNQLSVSLSIPLGTHA GAPRLSSSYSNTRGSSAIQTGVSGSAGEDNQFSYGVSAANNRSDENGSYN TLGANGSWQAPYATVGGSYSKSNSYDQASASLSGGVVAYRGGVILAPALG DTVGIIEAPDAAGARVGSYSSMYLDRRGRAILPYLSPYRQNEVELDPKGL SADVEFKSTSQKVAPTAGAVALVTFETSTGYSVLVRGHLADNTPLPFGAE VKDGGGTRVGFIAQGGQAMVRVNQQAGNLRVIWGDGIGESCSFDYKLPEG NLVKGHLVKGDYRRLEVICK >YPO0146 hypothetical protein MDTFFYSVSTWRSIKMYSQYWQVGLDIQMEAIRALAVIRRRNGWQLRYWW HKILPSGVLREGILHQPDILSEQLKLLRKQLPRHISLRIALPAQRILQHT IHVPDRRLREPERDGFIKASASRLFPVNSQALALDYCRETVASSELLITA ARQSEVQQWQACLEQAGLSSQVIDIAPCALRYMATATGLSGPYWLVHRLA NEWLWVSSSDMPFHSGVVAIETECRTQENDIRLLSALLAQLNMRGAGEDG APLPVYYSSVVKESLPENTRSWSPLTAFAHYQPPLPALPAAFTLAGGLAV RAADSLSAAGAGY >YPO3881 putative chaperone protein MLLLMTTCRVLTLPALTIGVLIMSALATSAVASVIAERTRIVFSEGSTEE SLQLVNSNSYPVAVQVWVDDGNLMATPDKAVSPILVLPPVFRLQPQAQRS LRLILSGGSKLPADRESAFWLNIYEIPPKATPKSGDESFVTLALRMQYKV FYRPKNLPAPGDILGKALTFSLERNGDSALIKVNNPTPYYASFAALTIGS AEGPPEMVAPFSQLDFPLNRAPISDNKTVNFDLIDDLGNRNSFSHELK >YPO2944 putative pili chaperone protein MLFGSVMFSKIIILVLSLTISSIPAFAAMTISGTRVIFPAAEKEVSIRTN NKGVQPALVQVWVDDGKTNANINSMKLPFMVTPPVFRVEPGKGQTVRMIY NGMALPQNKESVFWFNMLEIPAVKKEGNTQNKLELAFRTRIKVFYRPTSL ESNSAAQSAQLKWTLVDDNQKGRGVKVVNPTPYYISFDSGSITVGAKSVE IITDMVPPFSEKMFFPKLKLLGSTSISKMNYKILNDYGAAIDEELSFSQG QGVLVSKKK >YPO0812 general secretion pathway protein H MFHSQRAFTLLELLLAMIIISGLYYSVLITLPKGSGVVKSEAENLVQGLR YINQKIRHEGGVFGLKLSETHWRFYKFCCDDCHGIKDNFKINTKINCIWQ DSGNDKILSREYPDKLTSKLNVYGEDSIIDNVIGDNIKPQLVFSPEEEYS DFSLVLRNEENSECVEIKNNITGVSLFIHK >YPO4006 hypothetical protein MKLTYIKTKQGLSILPLSIILSLYGSSVAYADNIIPDIQAPAGQQAEVSI IETPPSTCRALTSYCIGMTETVVNIQAPDENGLSHNKYSKFDVVANGLFD VTTLNNRLAQEVNGNSFLQDKSATIILNEVNSSHASLLDGNLRVDGGNAH IIIANPAGINCRGCSFTNASHVTLTTGTPSFSDNKLNSFIVEQGNINIEK NPSYYMRTGLRYKGADKTYLDLFADTITVSGEINADDGYIVTGKNKVGFS LPGQPLQVSRLGNENTPVPGTVSLDVSEIGGMYTNKIRIHATDGTIKNKG AIRANDTLSLSSAANIDNSNGNISGKMVLLSSEGVINNSGGTILNNGEYD LLPSQGIKITSRGLNNEGGKIEYKNGSVEIATVNTIKNGKGTIKATSTQG RVRIKLHSNNLNNTGGSIISSGKIEGKVNNIRNNGGAIIGLGGVDLNETV LINDTGKIISDFN >YPO0811 general secretion pathway protein I MLEVIIALTIFCIAGLSIMKIISERLRWINILEQRMISSWVAENVLTEIK ILKIEQTNEWLMGQESMAGQLWYWQSRSIKLQDDRMEIIAVEVRNNKESE HPDFSLEGYKTTND >YPO3084 hypothetical protein MLEEIAVNPNWFWLSLGGLLLAAEMLGASGYLLWSGIAAVLVGVLVWLFP FSWEMQGVLFSILTVVSAFLWWYWLSKRTKPQPAMLNQRNHQLLGIRATL TEPTVDGYGRMKVGDSSWRIYCATELNPGTEVEVILVEGNTLHVRAVNR >YPO2759 putative mannose-resistant/Proteus-like fimbrial protein MSNFKKSVLVAAVLSLSAFAANAADQGKGKVTFTGSIIEAPCSITSEAAD QVVELGQISTTSLANMGSSEPRSFSIGLEKCDVATMKNVSVTFDGTPDGV DAEMLKLIGLADGAGIVITDEAGATIKRGVASVGKTLDQGSNSLKFSAYL KGTSADEGSVVPGEFSSVANFTLAYN >YPO4041 putative fimbrial chaperone MKDINSMIWRQQRLWAKTALFGIALWLTALTSQAAINLDRTRIIFNSTDK SASVILQNQSPSSPYLAQSWLENTKGQKIESPLVALPPMQRIDAGQKSQV RIMKLPDADKLPTDRETLFYFNVREIPPQSEMNNVVQIAIQNRIKLFYRP MAIKANYSDIWQEKLQISKLVGGLKINNPTPYYITLAYLSQNEQGNFPGF DSVMIAPFGTEFVKTPGYSGSRYNVGYMDDFGGIVIRTFNCLSAECQIQP AEKRR >YPO0699 fimbrial chaperone protein MKKLSLIALTSTVVFTSYTANAAIALDRTRIIYNGQDKSISLNISNENKT LPYLAQAWIENEQQQKVTTPLVATPPVQRVEAGKKSAVRISATPEALKLP QDRESLFYFNLREIPPRSEKSNVMQIALQTKIKLFYRPEGITPATGQIWQ EQLVLHKTAQGFRLENPTPYYITVVGLAEKGKSSADSNFQPLMVAPKSSA ELKSASFTAPVLTYINDYGGRPELSFSCSGSTCRAAKAI >YPO0272 putative type III secretion apparatus protein MTDVLPGLTALALAMMRPYGILLILPLFTARSLGSSLLRNGLIVAIALPV TPLFLSAPIITNSSPVTWIGVLCTELLIGVVMGFVAALPFWAMNMAGFLI DTLRGATMSTLFNPGMGVESSLFGVLFTQILTVLFLISGGFNQVLAALYG SYDSLPIGQGIQPAADLLLFLQTEWQMMFELCLCFALPALLVMVLADLSL GLINRSARQLNVFFLAMPIKSALALFLLLISLPYGLHHYLSRMSDTEQKI GTLIPLIKGGNDVH >YPO3877 putative fimbrial protein MKKITLAIALFSASTTVAMSASNNTITFQGEVTAQTCSVTVNGLEANPVV LLPTVSSSDLDASGQTKGKTTFTLGVSGCTSGSDDLDIKTVFIGSLVTAT GNLQNTGTAGNVELQLLKDATTTTGIDLNSGLAQDGIVLLAGDTSAEHDF AVQYYATGQSTPGSVIASVQYAVSYL >YPO0309 hypothetical protein MNPITLAIIVAFSTLVLPQTAWAACNSSGVGTYVCEGENNTAISLFGTDI AVETRPGFGITEHEITDSALSLTGSGTISYLDTNSSALDTDSRYSLYIKN DTLITEQSASINVQSNGSISSGVYIDNQSSDDSTIRVDLSGILSSSLSGA PALSIFSSAGNDSTIILNTHAISGVTGIQSDNNSQNGATITHVDVTGDIN VENSGVSIRNAANGGTSIINFNSKSINTEYNSFYIQNTNYVGGVITDINI DGDISSANSQAARIYNYTNGGLASLRFRANNVTGSTGLYIDNSSQNGAVT DIILTGDLTATSGSALQANAYSDEGNIETAIKLNNVYSLYDALNISDYTR SGNILHDLDISGTITAENGTGIKVMGAAGEGSSTMLINVNNITSSSQSLD INNYNFLGSAFSAITATGHLTAEWGQGAMLQTHSSLGDATTLIHFNDITA MSSGISLINEANQGTSTADITVTGQINVSHGEGITLNALTTDGRTLVNVD VNNIASEYDAIRLYNYNYNDNYATGVDDGTGADNGTSTIDLITRGALVSQ QGYGINIETNTADTYVTVGGLVHGGNGTAIGIHRLDNIQTSATLELQSGY ALEGVTQALVFTGSYAEINDAALDLANSHLVLGGAGDAAFDLTRIDNREE AILDGDPNRITGFGTLTKTNNSIWTLTGANMADGDANAFLSANIAGGILV LDNATLGLTPDAGALTGATVNRLSAADIAADPTRVATETGALTLAEGGAL SSLGDSVLSGNLISAGGILLSNHYTGGNGAATDDRLTVTGTYFGENNGSG EGAWLALDTVLGDDDSATDRLVINGDATGTTSVRVNNAGGLGDKTLNGIN LITVDGLAQDDTFLLAGDYVTTDGYQAVVAGAYAYTLQADGEAATAGRNW YLSSELMLTEGVRYQVGVPLYEQYPQVLAALNTLPTLQQRVGNRYGAPGA LADLNFDDNQWAWGRIEGSHQVTDPARSTSGSQREIDVWKLQTGIDVPLY QSQGGSLLTGGVNFTYGKAKADIHSFFGDGRINSAGYGLGTSLTWYGNNG VYVDGQLQTMWFDSDLSSRTAGHAVASGNNGRGYTSAIEAGKGYTLSHGL SLTPQMQVTYSRVDFDTFRDPFDSEVSLQEGDSLRGRLGVSLNKETTWSA KDGTTRRSHIYSHLDLHNEFLNGSKVQVSGVEFATRDERQSVGLGAGGTY EWQNGRYAVYGNVNLLGATRNISDNYAVGGTIGARVSW >YPO0815 general secretion pathway protein E MTDIESEFHTLPLTFSWSKSHGVLILPMAQGSQLICRKSATLEAILEGNR VAHSPILFNLVTDEEFENNLTERYQNNSADPYQTMSVISNEIDIYSFANE LSDDDDLLDINDEAPVIKLINSILVEAIKELASDIHIESFDKKLTVRFRI DGVLRKILELQRHVALLLVSRIKVMAKLDIAEKRIPQDGRIALNLAGRAL DVRVSVLPSSHGERVVMRLLDKNSIKLDLPSLGMSKDNCISMNTQVHKPH GIILVVGPTGSGKSTTLYAALMGIDANEKNIMTVEDPIEFDIPGISQTQV NPKIEMTFARSLRAILRQDPDVILIGEIRDIETAQIAVQASLTGHLVLST LHANSAIGAVTRLKDMNVEAFMLSSSLLAIISQRLVRRLCIACRQESSVT EKVLQRLNIDDKCSLVGSVYRAKGCNKCNLTGYRGRIALHEFLVVDNLLR GAIYKGLGEFELAKLASGAINSLLSDGISKVIAGLTTIEELVRICQEDDN GCI >YPO3944 putative invasin MLNYFRAILISWKWKLSHHTSRPHDVKEKGHPRKIKVVAWITLFFQFAFP LSLSFTPAIAAANTTNSAPTSVITPVNASILPPAARATEPYTLGPGDSIQ SIAKKYNITVDELKKLNAYRTFSKPFASLTTGDEIEVPRKESSFFSNNPN ENNKKDVDDLLARNAMGAGKLLSNDNTSDAASNMARSAVTNEINASSQQW LNQFGTARVQLNVDSDFKLDNSALDLLVPLKDSESSLLFTQLGVRNKDSR NTVNIGAGIRQYQGDWMYGANTFFDNDLTGKNRRVGVGAEVATDYLKFSA NTYFGLTGWHQSRDFSSYDERPADGFDIRTEAYLPAYPQLGGKLMYEKYR GDEVALFGKDDRQKDPHAVTLGVNYTPVPLVTIGAEHREGKGNNNNTSVN VQLNYRMGQPWNDQIDQSAVAANRTLAGSRYDLVERNNNIVLDYKKQELI HLVLPDRISGSGGGAITLTAQVRAKYGFSRIEWDATPLENAGGSTSPLTQ SSLSVTLPFYQHILRTSNTHTISAVAYDAQGNASNRAVTSIEVTRPETMV ISHLATTIDNATANGIATNTVQATVTDGDGQPIIGQLINFAVNTQATLST TEARTGANGTASTTLTHTVSGVSRVSVTLGSSSRSVDTTFVADESTAEIT AANLTVTTNDSVANGSDTNVVRAKVTDAYTNAVANQSVIFSASNGATVID QTVITNAEGIADSTLTNTTAGVSVVTATLGGQSQQVDTTFKPGSTAAISL VKLADRAVADGIDQNEIQVVLRDGTGNAVPNVPMSIQADNGAIVVASTPN TGVDGTINATFTNLRAGESVVSVTSPALVGMTMTMTFSADPRTAVVSTLA AIDNNAKADGTDTNVVRAWVVDANGNSVPGVSVTFDAGNGAVLAQNPVVT DRNGYAENTLTNLAIGTTTVKATTVTDPVGQTVNTHFVAGAVDTITLTVP VNGAVANGVNTNSVQAVVSDSGGNPVTGATVVFSSTNATAQVTTVIGTTG VDGIATATLTNTVAGTSNVVATIDTVNANIDTAFVAGAVATITLTAPVNG AVADGADTNQVDALVEDANGNPITGAAVVFSSANGATILSSTMNTGVNGV ASTLLTHTVAGTSNVVATVDTVNANIDTTFVAGAVATITLTTPVNGAVAD GANSNSVQAVVSDSDGNPVTGAAVVFSSANATAQITTVIGTTGADGIATA TLTNTVAGTSNVVATIDTVNANIDTAFVAGAVATITLTAPVNGAVADGAD TNQVDALVQDANGNAITGAAVVFSSANGADIIAPTMNTGVNGVASTLLTH TVAGTSNVVATIDTISANIDTAFVAGAVATITLTAPVNGAVADGADTNQV DALVEDANGNPITGAAVVFSSANGATILSSTMNTGVNGVASTFLTHTVAG TSNVVATIGSVTENIDTAFVAGAVATITLTAPVNGAVADGVNTNSVQAVV SDSDGNAVTGATVVFSSANATAQITTVIGTTGADGIATATLTNTVAGTSN VVATIDTVNANIDTTFVAGELENIVVSIINNNALANGADTNIVEAFVTDR FGNGVANQSLIFGTNGASIVGSSTVTTNLDGRVRASATHTVAGSSNTVIA ISGAHQGYARVTFVADVSTAQLKLTSFLDNQLANGKAGNIAQALVTDAHD NLLANQSVSFALDNGAVIESQGDASSASGIVLMRFNNTLAGMTTVTATLD STGQTETLETHFVAGKAASIEMTMTKDNAVANNIDTNEVQVLVTDVDGNA INGAVVNLTSNSGMNITPNSVTTGSDGTATATLTHTLAGSLPINARIDQV SKTINATFIADASTAQIIAGDMFIIVNDQVANGQAVNAVQARVTDSYGNP IKDQTVEFVLSNNGTIQYELDVTSVEGGVMVTFTNTLAGITNVTATVVSS GSSRNIDTTFIADVTTAHIAASDLMVIVDDAVADNLDKNEVHARVTDAKG NVLSGQTVIFTSGNGAAITTVNGISDGDGLTKATLTHTLAGTSVVTARVG NRVQSKDTTFIADRTTATIRASDLTITRNNALADGVATNAARVIVTDANG NPVPSMFVGYTSDNGALLTPTSGMTDSSGTFSTTFTHTTAGISKVTAAIV TMGISQTKDAVFIADRSTAHVSELIVVKNDSLANNSDRNIVQAHIKDAHG NVVTGMNVNFSATENVTLTANTVTTNSQGYAENTLRHNAPVTSAVTATVA TDLVGLTEDVRFVAGAGARIELFRLNDGAVADGIQTNRVEARVYDVSDNL VPNSNVVFSADNGGQLVQNDVQTDALGSAYVTVSNINTGVTKVTVTADGV SASTTTTFIADRDTATLVTDRFLITHDNAVANGVVENRVLLHLVDANDNS VSGVEVNFSATNGASINASAITDINGFAIGVLTNTLSGPSDVTVTLVTPG GTESLTVTPQFIADINTANIATGDFVIIDDGAVANSVDANEVRARVTDNQ GNAIAGYSVVFSSQNGATITTSGITGVDGWASAKLTHIKAGESGILARLS RPMATVHTLMPYFIADVSTATLQLFNFNPIPIIADGVMQFFVLGRVFDAN QNPVGGQQVAFSATNEVTLTESNGSISTPEGSVLLSVTSTQAGVHPITGT LVSNNYTDTFGAAFIANKNTAQLSTLMVVDNNALADGVTRNQVRAHVVDS TGNSVADMAVTFTANRGAQLSKVTVLTDNNGDAVNTLTNSLVGVTVVTAK LGTAGTPLTVDTVFTAGPLATLTLVTTVNNAFADNSATNTVQATLKDVSG NPIVGEVVAFAASNGATITATDGGVSNANGIVLATLTNGTAGVSTVTATI ETLTETTDTTFIAMKNLDVTVNGTTFNGDAGFPTTGFVGATFKVNSGGDN SLYDWSSSAPALVSVSGDGVVTFNAVFPTGTPTITISATPKGGGSPLSYS FRVNQWFINNNGATLNRADAITHCENVGYTMPTSTQVTNAATWMSGKRAV GNLWSEWGDFSAYTAPGWVPAEFFWLSNNHDASTALAIGLSTGTLTTMGD FMAITHVMCTRPI >YPO0813 general secretion pathway protein G MANKKTKGFTLLEIMVVIVILGLLASLTIPSLMSNKNRADQQKAVSDISA LENALDMYRLDNGDYPTEQQGIAALVTKPNVPPLPQRYPSDGYIRRLPTD PWGNSYQMNNPGKHGQIDIFSIGPDRLPETEDDIGNWITLSISET >YPO0598 putative hemolysin activator protein MSRFYYSILVAGVLLKIVAIPDASYGAELAPVQQSIHQQERQRALEERLA PPTPDVRLSAPSAFFSRIIFPLETPCFVINRIKISGAEPLPRWLPLQRIA DQAQGQCLGAKGINLLMSQMQNRLVDHGYVTTRVLAPQQDLNSGTLALNV VPGKIRGVELTPDSNRYVTLFSAFPARAGTLLDLRDIEQGLENLQRVPTV QANMVLIPGSAPGETDIILNWQQRKMWRLAASLDDSGTRSTGRYQGGATL FLDNPLSLSDLFYVSAGGALQRRGDKGTNNLTGHYSLPFGYWTAGMTASR YDYYQAVAGLNGDINYRGESENVAFQLSRLLHRNASQKTTFTYDVLTRSS KNYINDTEVEVQRRRTSAWRIGLQHRHFISQAILDAGISYQRGTRWFGAI PAQEEYFGEATALSKILRLNAQLDIPFVVMAQNLHYNLQYQRQSTNTPLT PQDQFSIGGRWSVRGFNGERTLIADRGWWVRNDIGWYLPLPGHELYVGVD YGEVGGRSGAYLLGRHLAGSAVGVRGNVLNTRYDLFAGKPLSKPNGFKTD SLAVGFNLNWLY >YPO0698 outer membrane usher protein MRIIKKIPIAMTTSLIMLSGAVSAIDFNTDAMDANDKQNIDLSHFTNVGY IMPGEYRLEINVNNHRIPEQVIAFYARDDEPNSSEVCLPEAVVEQFGLKP DVLQKITFWHEGQCADLRELAGLTTEVDLATSTLAINVPQDWMEYSDSNW VPSSQWDEGIPGFLLDYNVNSLFSKPKESGSTRNISLNGTSGLNAGPWRL RGDYQGNYSHNSGEQNSSTSTFDWSRIYMYRAIKSLAATLSVGENYFASS LFDTFRYAGASLSSDERMLPPNLRGYAPEVSGIARTNAKVTVSQQGRILY QTTVASGPFRIQELSDSVSGRLDVSVEEQDGTVQTFQVETAAVPYLTRPG AIRYKTSVGQPSTLNHGTEGPVFASGEFSWGVSNRWSLFGGAIGSGDYNA VSVGVGRDLYAFGAISTDITQTRASGLPNQETQSGKSLRVRYAKRFDELN SDISLAGNRFFEREFMSMNQYLGTRYFDNDLGRNKEMYTVTASKNFPDIQ TNINFSYSYQNYWDQPTSNSYSATVSHAFDAFSLKDMTVNLSASRSKNNG VNDDVLYLSFSVPLGNQQTLSYSGQHNGQGNNQTVNYSNSSAIDSSYRLS AGVNNSNDNGARGQFSGFYIHRSSIAETSLNVAYAQDDFTSTGVSMRGGA TVTAKGAALHGPGMSGGTRLMVNTDDIAGVPLEERNIRSNRFGIAVLNNI NSYYRTDTRIDINQLADDVEVKQSAVEFALTEGAIGYRRFAMMKGEKVLA TISLTDSSHPPFGSLVISAKGQELGIVSDDGFTYLSGVEPGETLDVVWSG AKQCQVAIPAVIQPQAQILLPCISVN >YPO0257 possible type III secretion protein MIVGLRQKPYLNLRNYKWMSLIYIMRKITGLILLFFATLLPYGKFSYVKA IPWQGEPFFIYSRGMTVSELLKDLGMNYGIPVVISSEINEHFTGKIRDKT PEKILSELAGRYNITWYYDGETLYFYPVQSIKREFISPDGLAANTLVKYL QRGDVLAGKNCAIKAIPHLDTLEVKGVPICIERVKSVSKMLSEQVRHQNQ NKETVKVFPLKYASAADSDYQYRDQNVRLPGLVSVLRELNQGNNLPLAGG NQPDGNQASSPVFSADPRQNAVIIRDRQANMPIYRSLITQLDQRPIQIEI SVTIIDVDAGDISQLGVDWSASASIGGTGVSFNSTFAKNNAEGFSTVIGD TGNFMVRLNALQKNSRARILSQPSVVTLNNIQAVLDKNVTFYTKLQGEKV AKLESVTSGSLLRVTPRMIETEGVQEVLLNLNIQDGQQQASTNSNEPLPE IRNSDISTQATLQVGQSLLLGGFIQDTQIESQNKIPLLGDIPLLGGLFRS TDKQSHSVVRLFLIKAVPVNAGE >YPO0682 MotA/TolQ/ExbB proton channel family protein MDLSVWGMYQNADVVVKGVMIGLVLASIVTWTILFSKGTELFRARRRLRQ EHEVIGAVTDLDTASERAEDFGQGSVSSLLLHEALNERLLSIESNDNNGI KERTAFRLERRVAAIGRQMGKGNGFLATIGAISPFVGLFGTVWGIMNSFI GIAHSQTTNLAVIAPGIAEALLATALGLVAAIPAVVIYNIFARQIGNYRA QVGDVAAQVLLLLSRDLDLASSAEVKSPRHPHQLRAG >YPO2490 putative hemolysin MRPTMNKNLYRIIFNKVRGMMIVVADIAASGRASSSPSSGLGHTQHRRIS ALSTLSFSLLLALGCVSLSVQAAIVADASAPGNQQPTIINSANGTPQVNI QAPSSGGVSRNVYSQFDVDGRGVILNNGHGVNQTELGGFIDGNPWLARGE ASIILNEVNSRDPSKLNGYIEVAGRKAQVVIANSAGITCEGCGFINANRV TLTTGQAQLNNGQLTGYDVERGDIVIQGTGMDSSRQDHTDLIARSVKVNA GIWANELSVTTGRNQVDAAHQNINAKAADGSPRPTVAVDVAHLGGMYAGK IRLIGTESGVGVHNAGEIGASAGDITITADGMLMNSGQINSSQQLVVNTA ADIENTGVLYAQGNTQLTTAGTLSNSGTLAAGGDTSVRAAEVNSTRNSVL GAGVKSDNSAITSGTLSVEASGKITAQGKNISGTAQRFTAHRLDLSGSQT QSRDITLIAQGGEIDLTGAELLASDRLSAATTALLRTDNASLIAEQITLD AQALSNVGGLIAHTGTTDFNLNLPGDVDNRGGTLLSSGTLSLQAESLNSN GNSLLGAGVQSDGRLTEIGDLRVTTRQDLIAHGQTLAAGAMALTGSRIDL ADSYTQAREMTLTANRGDISTQRATVLALDTLSINTAQTLNNQGGTLAGN TLALDLGQFDNQGGQVTASQDLTIDLQRDFSHQAGSTLQAGRDLTLTSLG AVTNDGQLVAGGTLSTHSDSLLNSGNLIATQAELNATGALINHGEILTLG GLDTDSNTLFNTGSIISAEATLNARERITNSGPDALIGATDENGTLALLA PVIENSDTVTHTDTAPTTTILGMGTVILAGGHARDGHYASAAQVLNLSGL IESGKDMLIYATTLTNSRHILTANTDFIVADTVTGTAVWTAENPDIPGGR YAEPPDGGADNSDYIGTEYTSVIAYNGIDQISPEAQLLAGGNLTPQVGTL ENFWSKVSAQGEIDLTGVTLQQDGWGDQQRLMEQTTSSGVWRYRTYKGGL WTREWGPEVSERATSEYASSFTAKTLSGSGTTINNGANPGAIAPPADRDN SGKDLAVEFNGISLTQPNGGLYQFTTDHTVGGGGYLIETHPAFANLNNWR GSDYVLQQLNNDPDVIFKRLGDNAYEQRLVRDQVLALTGQAVASDYRSAQ EQFEALFAAGLEYSKAFNIALGTHLSAEQMAALTHNIVLMETRDVAGQTV LVPVVYLAGVKPGDLQANGALIAAENISLTEVQGFTNAGAITATNDLKIS MAQDITLNNRGGLLQAGGDMQLSTLNSDIDLTSARINATNLQLDSGRDVI LRTDSAQLSSDNGAVSRDQTILGPLASINVSNNATINTGRDFIMQGASLN VGQDLQVTTGGDWQLETVQTRDQISTHDGRGSATSEHIRHLGSEVNVGGA LTANVDNLTAVGANINAATLEVQAQNISLSAATDSLHVTGESSSKRHTSS VNLYDETLLGSQLNATGDINLQAAQDITLRASAVQTDGALTLAAGGDVLL TTQTEQHDEQRNHTGLSKGIASSTLTRTEDSLSQTLAVGSMLSAGSIDVS GKNIAVMGSNVVADQDISLRAQENITVGTAQQSESESHLFEQKKSGLMST GGIGVTVGSSSTKMTDSGQSISSVGSTVGSVLGNVSMTAGEDLRVQGAEV LAGKDINLTGKNVSILAAENQLTQSHTVEQKQSGLTLALSGAVGSAVNTA VTTAKAASEESSGRLGALQGVKAALNGVQAVQAGQLVQAEGGDAASMFGI SASLGSQKSSSEQHQEQTHVTGSTLTAGNNLTINATGEGNAANSGDIVVQ GSQLQAGGDTTLDAARDVLLLGAANTQKTDGSNSSSGGSVGVSLGISGAS SGLSIFANANKGQGSEHGDGTSWTETTLDSGGTLSLYSGRDTSLVGAQVS GETVKVEVGRDLLLQSQQDSDNYDAKQQNSSVGGSFSPGSMTGSISINGS QDKLHSNFDSVQEQTGIFAGSGGFDITVGGHTQLDGAVIGSTATADKNTL DTGTLGFSDIDNQADFKVEHQSVGISTGGNIGSQFVGNMANGLLVGANNE GHADSTTHAAVSEGTITVRDTDNQQQNVDDLSRDVEQANNALSPIFDKEK EQNRLKEAQLIGEIGSQVGDVFRTQGQIIATQAATEKMQEVSEADREAAK ANWEKANPGQIATAEDINGQVYKTAYDQAFNASGYGTGGKFQQAVQAATA ALQGLAGGDIAKAIAGGSAPYLAEVIKQSTGDNEEARLAAHAVVGSVLAH LQGNSAVAGGAGALTGEIAADLIMQQLYPGKMVSELSETEKQTISALSTL AAGLAGGLTGDSSADAVAGAQAGKNAVENNALGSLGDIFGSQGAKYFEGA GSLERELSTDNTLTVQEKQAIRDHYLKGDLPEDVVKAILENTPASDTVMA LLQAESTKDYALALLSSLPLERAIAVLGKTANTLIKSSVVDKILDAQRVG SGLKPDPSHRGASYLNREQLMAGEVFNITGGDGVKRSLLQTKGTFNGKDG VFEYIYDKTGNVTHQRFIEGVGITGIPNQKAPKVK >YPO2940 fimbrial protein MLTTVFIAQSQPAQAASSCAGTADCHIQVSFGGEYVEDTCEVSINGASSA ESVSLPTLSTSKLNIDGAEAGNQAFQIALKLCPANRSVDLRFTAADSSRN PDVITGNLQNELADDYSRNVQVRLSKATGQQMFVGRENSVQEYVIPATGE DITHYFLAGYYAKGTNAVTPGQVKATAGIELVYK >YPO4102 inner membrane protein translocase component YidC MDSQRNLLLIALLFVSFMIWQAWQVDNNPQPTAQTTQQTTNTATGDKASQ AVPGSGQGQLITVKTDVLSLTINTRGGDIEQANLLAYPDTLGSSNTFELL ETTPSFVYQAQSGLTGKNGPDNPANGDRPLFEVPQTSFVLADGQDELRIP LTFTSKDGSVFIKTFVLKRNDYAIGVDYHVNNASAAPLELTLFGQLKQSI NLPKKRDTGSNNFALQTYRGAAYSSDETKYKKYSFSDIEDKNLDITTKGG WVAMLQQYFATAWIPAANETNTFYSAELGNGLAAIGFKGAPVVIQPGEQK QLSATLWVGPEIQNKMAEIAPHLDLTVDYGWLWFISQPLFKLLKFIHSFV GNWGFSIIVITFIVRGIMYPLTKAQYTSMAKMRLLQPKLAAMRERIGDDK QRMSQEMMALYKAEKVNPLGGCLPLIIQMPIFLALYYMLMSSVELRHAPF ILWIHDLSAQDPYYILPILMGITMYFIQKMSPTTVTDPMQQKIMTFMPVI FTVFFLWFPAGLVLYYIVSNLVTILQQQLIYRGLEKRGLHSREKKK >YPO0270 putative type III secretion apparatus protein MELLNSSYQLIALLFMLSVLPLLVVMGTAFLKLSVVFSLLRNALGVQQVP PNIAIYGLALVLTIFIMAPVGLDVQARLQNEELSNDIGALAHQIDQNALV PYRDFLQRNTDIEQVTFFNDIVQNKWPERYRDSVKPDSLLILMPAFTLSQ LNEAFKIGLLLFLPFVAIDLIVSNILLAMGMMMVSPMTLSLPFKLLVFVL VDGWSLVLGQLVGSYL >YPO1015 putative prepilin peptidase dependent protein MPLVVNVLSTPLNAQPTRTAGFTLPEMMLALSFGSLIALSTAQVLPKLSQ QISVLQQHYRLELVMNQAMGAMEKDLRRAGFCHGKCQGEAITIEHYLGET AHSCLIVAYDLNCNGRWEGAKHQESEYFGYRLRNKALESQRGELNCHGRG WEKLFDPRDVTVTHFSVTPLSGQLFKLRLVGHKTGNPAIHHQVTYLIRGN NV >YPO0806 prepilin peptidase MMDIQVFFVSYLIFGAMVGSFLNVLIYRLPIMLANLSSRSESHGEEIKMR SHLRNINLFQPGSFCHHCNESIPIKYNIPILGWIFLRGASRCCNKKISTR YLFIEVLAVIQTLLVLMIFKEDLLICTSLVLIWSLTALAFIDFDTYLLPD CMTIPLLWLGLLINIDTVFAPLTSAVLGAVSGYLFLWLSYWLFKIVRGVD GMGYGDFKLMAALGAWFGVSAVPFLILFSSFFGLVAYAIFYFFDKKDNGK EINYIAFGPYISLAGVLYLFLGSHVTNLFS >YPO1918 probable pili assembly chaperone MRLLSLFLLLFTISYDALAGLIAGSTRIIYQPELRERTLMLANTNDYPVV VQTWIDNGDVDSTPDQAKAPFMVLPAVFKMQAGSVQALRIINKGENLPSD RESVYWLNLYEIPPRERSNIDVHAQVAMAMNTQMKIFYRPNGLAPPPIDA MGKIKFSLKNIDNQYVIIANNPTPYFVSFGQIQLQSQQKNYLIAQSMDMM TGPFSTRPYYFEQPPTSLKGKFTVSYIYFDDAGNQVKNSQSVTVTL >YPO0267 flagellum-specific ATP synthase MKLPDIARLTPRLQQQLTRPSAPPEGLRYRGPIVEIGPTLLRASLPNVAQ GELCRIEPQGMLAEVVSIEQEMALLSPFASSDGLRCGQWVTPLGHMHRVQ VGADLAGRILDGLGAPIDGGPPLTGQWRELDCPPPSPLTRQPVEQMLTTG IRAIDGILSCGEGQRIGIFAAAGVGKSTLLSMLCADSAADVMVLALIGER GREVREFLEQVLTPEARARTVVVVATSDRPALERLKGLSTATTVAEYFRE RGLKVLLLADSLTRYARAAREIGLAAGEPPAAGSFPPSVFANLPRLLERT GNSDRGSITAFYTVLVEGDDMNEPVADEVRSLLDGHIVLSRRLAGAGHYP AIDIAASVSRIMPQIVSAGQLAMAQKLRRMLACYQEIELLVQIGEYQAGE DLQADEALQRYPAICAFLQQDHSLTRDPDTAHLDTTLEHLAQVVG >YPO0809 general secretion pathway protein K MNQNGIALLMVLCALFLMSTMVMASYNYWFDIYYLAKNSQQRQKEKWILL GAEEKFVSKLIKNTSEDRFNDNEFRRLLSGGRVTVGTWNVNFKSIDNTNC FNINALKTKISNPEEIIETYSWQVFKYLLLISGVGVKETQDTLERVVELY RSNLVIEQSINGLSTLKEIPYEADEINISSKMNRADFLKIAPVLCIRGDR KLLVNINMLDAGNSQYLQAALLNKVSARDIYDVISAKPNNGWDNIFIFYD LLSSHSPMSARNVNKNILDKLTVDEYFINYIFRIDHEDSYYQLITFIHAV GKSIAILNRRYSFSEQHH >YPO0691 hypothetical protein MTTGIKIMMFMGVLFIKIDITPLSNHGINIYNGGSMQLILNKDLINKKDN REKSAVVIISTRKGLKDKISEYVRLADIKNIKEIDDDIFSAASILIPDNV KGIIIDINENHDINTILDLMKVHTPRDCWCILVGDIDSISIAQQFIERGI LYLHIQSQLADLTQNLLKGIQIESDRKAFFISILGCRGGIGTTLLSYQLA HVITQIKKSPTLLLQGNQGSQDLDLITEKKMGEDITGYQKNFDLMRGNER KLSEVNEHNNKKHNFIIFDQPIHNARKEKTLDYISNSNCIILLIDHSMMS VRVAKEFIDTLERFKRDNRQAIRLFICLNENRPITKDMLTTSDIQSLLGH SIDTAIPYINNAKNSLNSPDYFGRKKTKVVELAKQSLGININLSSHTNMW IREKLNKLFK >YPO2181 hypothetical protein MSQSLLDLSGYIKFFVGLFALVNPVGILPVFISMTSYQAAAGRDKTNLTA NLSVAIILWISLFLGDAILTIFGISIDSFRIAGGILVVSIAMSMISGKLG EDKQNKQEKTETAVRESIGVVPLALPLMAGPGAISSTIVWSSRYHSWQNL LGLTVAIALFAFCCWLLFRAAPLLVRLLGQTGINVITRIMGLLLMALGIE FIVTGIKAIFPGLL >YPO2280 putative phage-related secreted protein MKKILLALTLLFSSCAFAGSELELNKVKLPEAISLIYSEVLKVPYMLDPQ LVNDERMITFRLTPDIDEREFVTRYLGNMNIRIWTKKGVDFIAPYTPKEP VKPRYTWTYTPQYRSVAYLSDILGGYVSGSFNNSGAVISDDSLKGSSGAS NYINRTGDILVYYGTKEDIAILKTLVTSLDTMSDEVVVSGYVFEVQTSQS DGSGILLAAKILSDKFNISVGAAGLDNFINIRTGSIDAIFNLLKTDSRFT VVSAPRLRVKNNASASFSVGSDVPVLGSVTVNNNTTTQSVEYRSSGVLFN VTPSIKSRTMDLKIQQQLSNFVTTETGVNNSPTLIKRDVTTEVSLADGDI ILLGGLAEQKDSKASSGWSFFGSRTSESNKTDIMVMLQVRKVDRSRATPR SAARSGELFRDNLN >YPO1707 putative fimbrial protein MKIKSSNVLIAAFAGLFIAQSAFAADGTITINGKITDTTCGISVNNGTKD GTVTLPVVSASALDGINSVAGTTPFNIVLTGCTGATMGNAYAHFEQGTTV EASTGRLNNSDIDGATGVQVRLLDKNSAPIVVGSGNQGNVVEDISGDGAT LSYYAQYYANEANVEAGLVATNVDYTIVYD >YPO2486 hypothetical protein MGRDLLLQSQQDSDNYDAKQQSSSVGGSFSPGSMTGSISINGSQDKLNSN FDSVQEQTGIFAGSGGFDITVGGHTQLDGAVIGSTVTADKNTLDTGTLGF SDIDNQADFKVEHQSVGISTGGNIGSQFVGNMANGLLVGANNEGHADSTT HAAVSEGTITVRDTDNQQQNVDDLSRDVEQANNALSPIFDKEKEQNRLKE AQLIGEIGSQVGDVFRTQGQIIATQAANEKMQGVSEADREAAKANWEKAN PGQVATAEDINGQVYKTAYDQAFNASGYGTGGKFQQTVQAATAALQGLAG GDIAKAIAGGSAPYLAEVIKQSTGDNEEARLAAHAVVGSVLAHLQGNSAV AGGAGALTGEIAADLIMQQLYPGKMVSELSETEKQTISALSTLAAGLAGG LTGDSSADAVAGAQAGKNAVENNALGLALKGCGIAAPCRSLIAKQVLEIG VKAGITGIVAKEIADKISEDDLDHLVTLKMMGNDEITEKYLNSLQDKYAP AHTGGDQNAGSGPTDTGGNQIADNSPDHTGNDQSTGQGATNTGNTDGKPD AGGNVLVNPGADPLTKKDIVYLSENPNGKIDTVINETLSGKKNFTSSTTL TSDEALAAGLKFLGTGYKEIGKSGSGVYHSADGTKEFRIDSGSIDGAHAP GVPHVHFGVKNPETGKYISNNHVPYKD >YPO0617 hypothetical protein MMTHAVLTARIAKISLTCSILSWSLLIVGCATDRLDLAPASYTEPWTPDG NARASMGGGNFSVPPNPIVAELAQPPTIKSDHAYSLPELIDIAQRQNPDT RIAWQQARQAALAVGMGEAIFLPIISASVIGGYQRTTTPLPYAIGNEKDL KTTGSAVIPALALQWLIFDFGQRSALLDAAKQTSYAANVTFNGMHQKLIY DVTRTYFQYGAAQAQSQIAKQTLQNSLKIQDAAEERQKKGIATTVEVALA RQQVAQSQLRRVVAKGTERDAYQALLGAMGVSPSLDIKAAYTEDRALPDG ISAPTEKMIQLALSQRPDVLASYAAVEAAKAGIKATEADFLPKVYLAGAV AGGDGHFDIQGLPGISPQTSSSSILVGVSVPLYDGGIRAARVKEAESRAA VAAEGFKKTQELAVREIVVAADTLRSALESNQAALNLVKTSFISYDAALE SYRSGVGTITVANEAANGLLNAQQMSTDAHAASLVAAANLAFVMGKMTNT SPPLELLH >YPO3879 putative outer membrane usher protein MVQARVILKKNFSGRRKALTLCITLILHIDTAFGQEEPQNFEFDESLFLG TKYASGLTQLNKKNSITAGNYDAVDVLVNNKLFKRMSVQFIKDANSSEVY PCLSDELLTAAGVELGRENSTPPKEPHVTEANTPITETHAPTNQCLPLST RVKGASFRFDQAKLRLELSIPQALLQKRPRGYIERAEWQEGEKLAFINYS ANAYRSDTRGQQKRTSDFGFIGLKSGINLGLWQVRQQSNVRYASNDSGSD TQWNSIRTYVQRPIPQLDSQLTLGETFTDSTLFGSMSFLGAKMATDQRMW PVSMRGFSPEVRGVASTNARVIIRQNGREIYETNVAPGPFVINDLFSTSS QGDLNVEVIEANGSRSTFTVPFSAVPDSMRPGVSRYNAVIGESRDFTNID NYFTDFTYERGLTNQLTANSGVRLAKDYTALLAGGVLGTPVGALGLNATY SHAKVENDKTQDGWRMQATYSQTFNQTGTTFSLAGYRYSTKGYRDLNDVF GVRSMQKNGGTWDSSTYKQRSQFTTTINQDLGNWGQLYASASTSDYYNDT ARDTQLQLGYSNSYQQISYNLAVSRQRSVYTSTLYNWDSPDTDETATTTR YGNTENIATFTVSIPLNIGSNNQYLSMSASRNPKSGNNYQTSLSGTAGER NSFNYALNAGYDDSNFGSSSNNWGANVQKQFPNATVNGSYSRGNNYTQYG AGARGAAVIHRQGVTLGPYLGETFGLIEANGAQGARIDSNGFALVPALTP YNYNTIGLDTKGINRNTELKENQGRVVPYAGAAVKVKFETLTGYAVLIQA EGEGLPLGADVYNSKDELVGMVGQGNQIYARIADNKGTLDVRWGESSGDQ CQLPYAFNRQDTEQDIIHITASCRR >YPO3721 hemolysin MKKHTFKLSPAGKLAAAVTIISVSVATCYAAGIVGAGDSAHKPDVSSVNG TSVINIVQPSASGLSHNQFQDFNVGEKGAVLNNATSAGNSILAGQLAANQ NLNGQAASIILNEVISRNPSLLLGQQEIFGMTADYILANPNGITCNGCGF MNTNRESLVVGNPLIEQGSLKGFETFNNNNWLIIQDKGLTANKILDLIAP RIEVTGMVTSTEAINALSGNNQISTDGQILESRQEDHPNRPTSLGGWFSS LFSSESEESIDGKYLGSMQSGRINLVSTREGSGVKIAGSLNGSEEINATI KGKLQLEAAKLGGNDININANSIQAFGNLHKNEDNGGVTQSLERTQLKGK NIAIVANKKNQLSAVKIDADNVTLRGGELVLDERILTKTEQESSSDGGNG VLGLGKWNWSENKEEKQQTSIGTTITAKNNASLESTQDDIKLSAATITAG KNLAIKAKKDLHIDGAIEENSIHDYGHNYKHMVKDESWNNKTTKQTLNKT TLEAGKNLGLTAENKITTQGIKASAGGDVVIDANDVKIGVQKTSNQETTD GKHERNLGLGGVDHNNNDKYAETSHSSEITADGNILISVKDDVAITGSKV KATKDGFVQAKEGGIKIDNAISTTTNKVDERTGVAFDITGSSKKANNSEE KSTGSEVVSEANLKIISKKDVDVIGSLVKSAGELGIETLGDINVAAAQEK QKIDEQKTLLTIDGFTSDDGKNQYQAGLKVEHTSESEKTEKVINHGSTLE GGTVKLEADKDVTFTGSQLNTTKGDADITAENVSFVAAQDTTTSNKEKET VGVNAHYTGGMDKAGSGAGVSYEETKTDSEKSTAVVSHTDVKGDLNLNAK QEITNQGTDHNVEGSYAANATNVNNLAAENSETTTTTTNTVDVKYGGNIA YDGVTRPVEKTIESGKKLDVGGVIENVGNVAPDSVNAGVDLSVNVGEKEN KSSNSQAVVTSIKSGDISITAKEDVKDQGTHYQADKGGIKIDAANHTFES AVNRAEESEKVVSGGVDMRIYTTTGEDINVDAKGKGENKQQEVKAEQAQT GSMKAVGDIIINVQENARYQGTDLDSGDGKIAITAGEEIKFEQATSHLSE NHNKIDANAKANFGTKPNSKDFGGGLGGGHSQGSTSADIAQVSHLHGKQG IELNAGKDLTLQGTEFGSKNAATGDVQLTAGGKVDFQAAQSQSSKQDMTW SASVKAGKSKSNSTSENDDGTKTHTNNKGFSAGAEANVKNTDETSLTHQG GIINSNGAVTIKADGKDQQAIHLQNTNIISQETILNADNGGIVMESAQDK EHKNNWNVNTNLNGSQKNTIKSDDQGVVDKDSAKKIHNAAIKLDGGVDKL DSVTQQNTHINSDKVTLNSAKNTELAGAVLQANQISGQIGGDLNVISREN RLNKVNVSAALGGSHSNAKQDSLISQVANASPIMSDKIKNKLEEKSTKIF DKVENKFNTLGKEKDDSVQTISYTKDGQTVKISEADEKKETKDKWWQKGA KSVGKKIKSAVQDEQVVGGNGSVKANVEVVESQGVEEQSAIRGTQNVDLT VKGKTDLVGGKISSKNSDVKLKTNGLETQDINGKYTEGGARLNASSSVMD MISDGAKDVMDGKAPLVSGHGKSEQKNATGGITRE >YPO2737 ccmD, putative heme exporter protein D MTPAFHSWAEFFAMGNYAFYVWLAVAATLLSLLGLLMHTLWQHKQLLADI HRRQAREQRIRQAQLNQTSMHQVPLHQAPLHQAPLQQAPQHIANLQEKRP >YPO3157 clpP, ATP-dependent Clp protease proteolytic subunit MSYSGERDQFAPNMALVPMVVEQTSRGERSYDIFSRLLKERIIFLTGQVE DHMANLITAQMLFLEAENPEKDIFLYINSPGGVITAGMSIYDTMQFIKPD VSTICMGQACSMGAFLLTAGAKGKRFCLPNSRVMIHQPLGGFQGQATDIE IHAKEILKVKSRMNELMAYHTGKSLEEIERDTERDRFLSAEQSVEYGLVD SVFTRRD >YPO0075 cpxP, hypothetical protein MRKVTTLVMASMFVLGSSAAFAADNTKVTEGYHGDGKMMMNKKGDRGHHN MFDGINLTEQQRQQMRDLMRQSHQSQPRLDLEDREAMHKLITADKFDEAA VRAQAEKMSQNQIERHVEMAKVRNQMYNLLTPEQKEALNKKHQERIEKLQ QKPAAQPSSAQK >YPO3296 ffh, signal recognition particle protein MFENLTDRLSRTLRNISGRGRLTEENIKETLREVRMALLEADVALPVVRD FINRVKERAVGHEVNKSLTPGQEFVKIVKNELISAMGEVNNELNLAAQPP AVVLMAGLQGAGKTTSVAKLGKFLKEKQKKKVLVVSADVYRPAAIKQLET LAQGVGIDFFPSDAQEKPIDIVNRALQQAKLKFYDVLIVDTAGRLHVDEA MMDEIKQVHAAIKPVETLFVVDAMTGQDAANTAKAFNEALPLTGVVLTKV DGDARGGAALSIRHITGKPIKFLGVGEKSDALEPFHPDRIASRILGMGDV LSLIEDIESKVDRAQAEKLATKLKKGDGFDLNDFLDQLKQMRNMGGMASM LSKMPGAGQLPENVKSQMDDKVTVRMEAIINSMTLKERAKPEIIKGSRKR RIATGSGVQVQDVNRLLKQFDEMQRMMKKMKNGGLAKMMRGMKGMMPPGF PGR >YPO1797 flgM, negative regulator of flagellin synthesis MSSIDRTQPLSPVTQVQARESHDVAQQTRQSATQTKTPVSGTEVKLSDAQ AKLMQPGSQDINVERVETLKQAIRSGQLTMDTGKIADALLKNVADELKNH >YPO1796 flgN, flagella synthesis protein FlgN MVESLQTNLDQQLDLLESLTNVVAQEQQLLCSGRIQGWVLQGVTEQKSSI LATLAYLDQTRITTETTANIQAPYTRMPALAERWQRLLQLTERLRYSNLH NGLLLQQHIEHNNQALAVLNTRHGQSLYGPDGQAKGANILGRKIGI >YPO1791 flhA, flagellar biosynthesis protein MANLAALLRLPGNFKDTQWQILAGPILILMILSMMILPLPPFALDLLFTF NIALSIMVLLVAMFTQRTLDFAAFPTILLFSTLLRLSLNVASTRIILMDG HTGGAAAGRVVEAFGHFLVGGNFAIGIVVFVILVVINFMVITKGAGRIAE VGARFVLDGMPGKQMAIDADLNAGLIGEDEAKKRRSDVTQEADFYGSMDG ASKFVRGDAVAGLLIMVINVVGGLLVGVLQHNMAFGHAAETYTLLTIGDG LVAQIPALVISTASGVIVTRVSTDQDVGQQMVTQLFNNPRVMVLSASVLG LLGMVPGMPNFVFLLFTAALLALAWRLRGKQTQQPVAVEAPVVQDQQQGA EATWADVQLEDPLGMEVGYRLIPMVDFQQNGELLGRIRSIRKKFAQEMGY LPPVVHIRDNLELPPANYRILMKGVEIGSGEAHPGRWLAINPGNAVGTLP GEATHDPAFGLAAVWIESALREQAQIQGFTVVEASTVVATHLNHVLSQYA NELFGRQETQQLLDRVTQEMPKLTEDFIPGVVTLTTLHKVLQNLLMERVS IRDMRTIIETLAEHAPNQADPYELTATVRVALGRSIAQQWFPGNGEIQVI GLDAALERLLLQALQGGSGLEPGLADRLLDQSKQALQRQEMLGAPPVLLV NHALRALLARFLRRSLPQMVVLSNLEIGDNRQIRMTSTIGSA >YPO1790 flhB, flagellar biosynthesis protein MAEDSDQEKSEEPTASKLEKAREKGQIPRSRELTSMLMLGAGLTILWMSG ESMARQLSAMVAQGLHFDHSMVSNDKQMLRQIGMLLRQTLLAMLPIFAGL VIVALAVPMLLGGVLFSGESIKFDLKRMSPVAGLKRMFSSQALAELLKAI LKATLVGWVTGLFLWHNWPDMMRLIAAPPVAALGDALHLIIFCGLVVVLG LSPMVGFDVFYQITSHIKKLRMTKQDIRDEFKNQEGDPHVKGRIRQQQRA MARRRMMVDVPKADVIVTNPTHYAVALQYNESKMSAPKVLAKGAGAVALR IRELGAEHRIPLLEAPPLARALFRHSEVGQHIPATLYAAVAEVLAWVYQL KRWKREGGLIPKKPEHLPVPEALDFATESETKSETD >YPO0706 flhB, flagellar biosynthesis protein MSNSSGEKSEKPTAGKLSKARKKGDIPRSKDVTMAAGLVTSFILLSLFLP YYKALVSQSFVSVAQLASQLDDQGALEQFLLANLFIFAKFLATLIPIPLF SMLATLIPGGWNFTPVKLIPDLKKLSPLAGIKRIFSASNGTEVLKMLAKC SIVLYTLYLVVHSSLDDLLHLQTLPLEEAITQGFAQYHHILLYFIAIVVV FAAIDIPLSHHLFTKKMKMTKQEVKQEHKNNDGNPEIKSRVRQLQRQYAI GQINKTVPSADVIITNPTHFSVALKYAPEKASAPYIVAKGKDDIALYIRS IAQKHKIEIVEFPPLARAIYHTTKVNQQIPAQLYRAIAQVLTYVMQIKSW RSGQASKPVLNTHLGLPKEMQRFHDET >YPO0713 fliE, putative flagellar hook-basal body complex protein MDNIDSINMPRSQSPVMLEMRQMAAMAGSGLEFGTIQPAATNSPFFPVEK GANNLSFSQVLNGAIKSVDQLQHVASEKQTAMDMGISDDLTGTMLASQKA SVAFSAMVQVRNKLTSALDDVMNTAL >YPO1831 fliE, flagellar basal body protein MSVQGIEGVLQQLQVTALQASGSAKTLPAEAGFASELKAAIGKISENQQV ARTSAQNFELGVPGVGLNDVMVNAQKSSVSLQLGIQVRNKLVAAYQEVMN MGV >YPO0714 fliF, flagellar M-ring protein MLDKIKQKLSPGQLGENTKTILMSAVALLVTAAIIFSLWRSSQGYTALFG SQENIPITQVVEVLEGEAIAYRINPDNGQVLVAENQLGKARILLAAKGIT ATLPIGYELMDKESMLGSSQFIQNVRYKRSLEGELAQSMMALSAVEYARV HLGMSEASSFAISNHADNSASVVLRLRYGQTLSTEQVGAIVQLVAGSIPG MKPANVRVVDQHGELLSQAYQANSEGVPSVKSGTELAHYLQSTTEKNIAN LLNSVIGANNYRISVSTQLDMSRIEETAEHYGPDPRINDENIQQENSNDD MAMGIPGSLSNQPIPQSQAGQTPAAVSRSQAQRKYIYDRNIRHVRYPGYK LEKMTVAVVLNKSLPVLEQWTPEQQEELKRLIEDAAGIDVKRGDSLTINM MAFAVPTLIDEPVMPWWQEPSTFRWAELLGIGLLSLLVLWFGVRPLMKRY SRKGSENLPLAISSASADEALDHVDTGVDGAESSPRTENAFSASSLWKSD DLPEQGSGLETKIAHLQQLAQSETERTAEVIKQWINSNERIKSQPE >YPO1830 fliF, flagellar M-ring protein MNASITGGENRENTFTMTLARLRANPKIPLLIAAAAAIAIIVALMLWAKS PDYRVLYSNLSDRDGGDIVTQLTQLNIPYRFADNGGALLIPAEKVHETRL RLAQQGLPKGGAVGFELLDQEKFGISQFSEQINYQRALEGELSRTIGTLG PVLNVRVHLAMPKPSLFVREQKSPTASVTLALQPGRALDDGQINAIVYMV SSSVAGLPPGNVTVVDQTGRLLTQSDSAGRDLNASQLKFTSEVENRYQRR IENILAPMVGNGNVHAQVTAQVDFASREQTDEEYKPNQAANQGAVRSQQV STSEQLGGTNVGGVPGALSNQPPVAPIAPIEIPQPAGAAANNAAPANTAA TANANTTATAAKASSSNSRHDQTTNFEVDRTIRHTQQQAGMVQRLSVAVV VNYTSDKAGKPIALSKDQLAQVESLTREAMGFSTVRGDTLNVVNTPFTAS DDTRGSSLPFWQQQSFFDQLLNAGRYLLILLVAWILWRKLLRPMLAKKQV ADKAAASVNNIVQTAQAAETVKQSKEELALRKKNQQRVSAEVQAQRIREL ADKDPRVVALVIRQWMSNDQ >YPO0716 fliH, flagellar assembly protein MMLIKNTPRAGAVKLRVHQFPPLRKVRQVAPSAADQTLDPAEYQKQLMAG FQEGISQGFDKGLAEGKEEGYQEGVRLGHDDGLKKGRIEGRQSELASFND VIKPFSGYITQLHTYLETYEQRRRDELLQLVEKVTRQVIRCELALQPAQL LTLVEEALAALPMVPQQLKVYLNPAEFGRINDVAPEKVQAWGLAADPDMV GGECRIVTETTEIDVGCQHRLDQCIGALHSSFLTEPHHE >YPO1828 fliH, flagellar assembly protein MSDRINALPWQPWSLKDFASQSEAPLSESMPDISLLFPNEPMEATAAVDE QQVLVNLQLEAEKQGRQQGFAKGLQEGLDKGYQTGLEEGHQQALADAQQQ LAPMTAHWQVMVTDFQNTLDTLDSVIASRLVQIALAAAKQIIGQPAICDG TALLAQIQQMIQQEPMFAGKTQLRVNPDDLAIVEQRLGSTLSLHGWRLLG DSQIHAGGCKVSAEEGDLDASLATRWHELCRLAAPGEL >YPO0717 fliI, flagellum-specific ATP synthase MSESPALDHALKSIENIHLARVAGRLVRVTGLLLESVGCRLAIGQRCRIE SVDETFIEAQVVGFDRDITYLMPFKHPGGVLGGARVFPSEQDGELLIGDS WLGRVINGLGEPLDGKGQLGGSTPLQQQLPQIHPLQRRAVDTPLDVGVNA INGLLTIGKGQRVGLMAGSGVGKSVLLGMITRYTQADVVVVGLIGERGRE VKEFIEHSLQAAGMAKSVVVAAPADESPLMRIKATELCHAIATYYRDKGH DVLLLVDSLTRYAMAQREIALSLGEPPATKGYPPSAFSIIPRLAESAGNS SGNGTMTAIYTVLAEGDDQQDPIVDCARAVLDGHIVLSRKLAEAGHYPAI DISQSISRCMSQVIGSQQAKAASLLKQCYADYMAIKPLIPLGGYVAGADP MADQAVHYYPAITQFLRQEVGHPALFSASVEQLTGMFPSFAPTDEA >YPO1827 fliI, flagellum-specific ATP synthase MNCAVWPRRGNCDAPRLSRWLTSLDKFEERISQTTTIRRYGRLTRATGLV LEATGLQLPLGATCLIERHNGGEVQEVESEVVGFNGQHLFLMPLEDVEGI VPGARVYARVTTSGTSASKQSISSKQSIPSKQSFASKQLPLGPELLGRVL DGSAKPLDGLPAPETGYRAPLITPPINPLQRTAIVQVLDVGVRTINALLT VGRGQRMGLFAGSGVGKSVLLGMMARYTQADVIVVGLIGERGREVKDFIE NILGAEGRARSVVIAAPADVSPLLRMQGAAYATRIAEDFRDRGQHVLLIM DSLTRYAMAQREIALAIGEPPATKGYPPSVFAKLPALVERAGNGVSGGGS ITAFYTVLTEGDDQQDPIADSARAILDGHVVLSRRLAESGHYPAIDIEAS ISRAMTSLIDDDHYSRVRQFKQLLASYQRNRDLISVGAYAAGSDPLLDKA IALYPQMEAFLQQGMFERSSFDDACQHLKVLFPG >YPO1826 fliJ, flagellar protein MKSQSPLVTLCDLAQKAVEQASTQLGHVRQSYQNAEQQLTMLLTYQDEYR ERLNDTLCNGMASSSWQNYQQFIQTLEQAIDQHRKQLAQWSIKVEQAVKY WQEKQQRLNAFETLQERAETTQRQQENRLDQKLMDEFAQRASQRSLNL >YPO0710 fliN, flagellar switch protein MTDQQIELNNDLDFTLALDESAISPTEHFDSVINSPEIINTPEKTATKTD EQKRKMSLFSRIPVTLTLEVASVEIPLSELLTVNNDSVIELDKLAGEPLD IRVNGIMFGQAEVVVINEKYGLRIININSQNLGELAL >YPO1822 fliN, flagellar motor switch protein MSDPKFPSADGKESVDDLWAYAFNEQQATEKPTATTEGVFKSLEAPEGLG NLQDIDLILDIPVKLSVELGRTKMTIKELLRLSQGSVVSLDGLAGEPLDI LINGYLIAQGEVVVVADKYGVRITDIITSSERMRRLSR >YPO0709 fliP, putative flagellar assembly protein MSRSLRAITPVTIISRGLLVGGLLYSPLLLAQEGGITLFNTVQTATGQDY NVKIEILILMTLLGLLPIMMLMMTCFTRFIIVLAILRQALGLQQSPPNKV LTGIALALTLLVMRPVWTKIHQDAVIPFQQDEITLSQALGRAEAPLKNYM LAQTSTKSLDQMMAIAQVSGEPQQQDLSVVTPAYVLSELKTAFQMGFMIY IPFLVIDLIVASILMAMGMMMLSPLIVSLPFKLMLFVLCDGWTLMVGTLT ASVQGL >YPO1820 fliP, flagellar biosynthesis protein MSVINKTTLGLLTLFCSPSVLAQLPGIISQPLANGGQSWSLPVQTLVFIT TLSFLPAALLMMTSFTRIIIVLGLLRNAMGTPSAPPNQVMLGLALFLTFF IMSPVFDKVYQEAYLPFSQDKISMDVALDKGSQPLREFMLRQTRESDLAL YARLANLPPLEGPEMVPMRILLPAYVTSELKTAFQIGFTVFIPFLIIDLV VASVLMALGMMMVPPASISLPFKLMLFVLVDGWQLLLGSLAQSFYS >YPO0708 fliQ, putative flagellar assembly protein MTTDIAGDIIAMGLHLVLMISIVAIVPSLLIGLLVSIFQATTQINEQTLS FLPRLVMTMLVLIFAGKWMMIKLSDFTVSIFQQAAQLVG >YPO1820a fliQ, flagellar biosynthesis protein MTPESVMALGTEAMKIALALAAPLLLAALISGLIVSLLQAATQINEMTLS FIPKILAVFTTMVIAGPWMLNLILDYMRNLFTSLPTLIG >YPO1819 fliR, flagellar biosynthesis protein MLSFDTHQLSVWVSQYFWPLVRVLALIGTAPLLSEKQINKKVKIGLGVLI TFLIAPSLPPVNIPLFSSAALWVAIQQILIGVALGVTMQFAFAAVRLSGE VIGLQMGLSFATFFDPSGGPNMPVLSRLLNILVTLLFLSFDGHLWLISLL ADSFHTLPIQFAPLNGNGFLTLAQSGSMIFMNGLMLALPLITLLLTLNMA LGMLNRMTPQLSVFVIGFPLTLTVGIISLGLIMPLLAPFTEHLFSEFFDR LAEVLSGMAN >YPO0707 fliR, putative flagellar assembly protein MGIDIHAMTAPLFALWLPFVRILSFLHFCPVIRHKAFTRKAKIGTALLLA ILITPMISQPVVSGELLSIENLLLAGEQILWGWLFGSMLHLVLAALEAAG QILSMNMGLGMAMMNDPTSGASTAVISQIIFTFSVLIFFTLNGHLLFVTI LLKSFSSWPIGEAINDFSLRSLALSLGWILSSATLLALPTTFIMLIVQGS FGLLNRISPTLNLFSLGFPIGMLFGLLCLLLLAINIPDHYLHLTNEILTQ FERMKVH >YPO0741 fliS, putative flagellar protein MMYDEPMAGLYQQTDIAIQAAATPHQLVMMLFDGLRDELICAKGHIEAGR YEHKVKSINKCINILNGLTSVLNYEDGGDLSVTISKLYDYCVYRLYEASN LLSIEIIAEVEGILAALYQGWEGMKH >YPO1840 fliS, flagellar protein FliS MYKRSGSQAYAQVGLESGVMSASPHQLIVMLFDGAQSALIRARILMSQGN IPAKGAAISKAIDIINNGLSAGLNLDKGGEMAENLSALYDYMSRRLLYAN LHNDEQAINEVSALLENIADAWRQIGPNYQPN >YPO3814 ftsY, cell division protein MAKEKKRGFFSWLGLGRQSEEPAAEPLATEKEGVTEQEDVIEQTGVIEPT DVIEQTVEHVISEKTTEAPAENAFIEVELREQVAAVIPTEPNNAIMSEGV PDTLPERAVAESVVAELVETGDNAAIVHDEIIEPITQVTEAGGELSLVKP GIEGDTTEQGGPTDNLPKRSLTEDNLIIDVPTPQAVVEESRVDAVEQPTE TSEVEEVEEVEEVEEVEEVEEKIIPVAAQEQERPTKEGFFARLKRSLIKT KQNLGSGFMGLFSGKKIDDDLFEELEEQLLIADVGVETTRKIITSLTEHT SRKQLKDADALYGKLKEEMSEILSKVDKPLDVSGKSPYVILMVGVNGVGK TTTIGKLARQFQAEGKSVMLAAGDTFRAAAVEQLQVWGERNKIAVVAQHT GADSASVIFDAIQAAKARGIDVLLADTAGRLQNKAHLMEELKKIVRVMKK LDGDAPHEVMLTLDASTGQNAVSQAKLFNEAVGLTGITLTKLDGTAKGGV IFAIADQFEIPIRYIGVGEGIEDLRPFKADEFIEALFARED >YPO3247 hmwA, putative adhesin MNSKLYKLIFCRRLGCLIAVGEFTRSYGRAFSSKGGQAGNNQRRAVGILS RLAMMTGLALGIFPLLVLAHPVLPVNGHVVIGQGMLDQQSSTLTVTQQTD KLAINWDSFDIAHGHSVIYAQPGSQSIALNQVQGQSASQIYGRLQANGQV FLLNPRGILFGKEAQVNVGGLVASTKYMSNPEFLSGDYRLIGGESEGNII NQANLRSAPGGYIALVGNRIDNQRSGSITTPQGNTVLAVGHSVTLNLDHG NLLGVQIQGETVAALIQNGGLIQADGGVIQLTAKGKDMLMDTVIDNTGIL QAKGLSAKNGAIYLDGGGEGVVSQMGTIDVNNQQGRGGRAVVEGKRIYLN KNSNIKAKGTAGGGTVLVGGGWQGKDNQIRNATAVVMDKGSDIDVSASRN GPGGSAVLWSEDYTGFHGNIRARGGPQSGDGGQVETSSQRNLQAFGQVDA SAVRGSAGYWLLDPAEVTIVSSGAESGVMTKVGNIPAEFFSSAHIFIPTA NITQILNSSINTQLNSGTNVTITTSNSSLTGCQWCNITVQADITKTAGAD ATLTLQADGNIVVNNNITADAGKLNLNLLAGNTTADSAITLNNSKVLLNG GDFLAKHANDNNTARIGLLGGRYDVGNFTLDGNTALASQVGVNISNAANI SVAGETVISGVSSNSRGQGWRGIDISNNSILTGVGNMTFSIGSNSNVSWM GAFTNATITSDKNIIFQGTGSSSGGVDFVNSRILSKSGRVLFDINGNIVV KNVYGLRVNNSQLSAKDVKFAVNVTGVDGFLLRDSHVTATSGDINANANT INKGIWISGKTNLNASGNVNLHGVTTNSAYAGADAIKISGNSSSNNVNIT AGGHISLIAVNGGKEIGSTVSVDYANIIAKNGDFNLNITGMKGSPFNNAT ITANNISMNGNITANDAVLMTNTFLTAKGDIKTDLTSPTKGLWFRGNGGM TAANNILLVANSTSSGETVKINASSSNKMNITAGKDISIIAGNSKTATGP NINIENVNIETNNGNFTTNGITSTWLSGVNVSANGVDITSNSTGTGGIVL DNTNILTTVGDINTIVTNSSGKGIWIKSNSTLNSNKDITLVGVSAGQNEG VIIQGSSDASRNNISAQGNITLIGKMGNGSGQHSLINLGNVSLTSSGRNI DINGSSAGTGDVYFTNVELNATAGNVSIYAETKTALSTSLNAVLSLGGNN SIKAQNGWLIGKAFNTTQGAGIGFRANSSLSVDGNIILKGETEGVGATRK GIDFYGANTLNIIKGSQLSLLGENKGAQDTAGGNGISYTSLAKLTVNNNG SLKMEGRSTSGTGINFPSSNNTLVFNGDGDTLIKGSSVAGTGAAISGVVN NSTGPMTIEGISTDGAGVHLFSAEHRIDRINVTGSSTHAEGLRISGNAAI VDTTLTGKSINGSGVKIDSLPGSSVVTRSVLDNATLNGSSSSGKGVEITS DINGIHHSSINGTTTGTGYGIDIGENSNVTGTSEADLLILQGVATTGTGT GIKLNGNNDLSNTSLNSSAVDGIALDITGPLANQGNVILNGTASGSGIGA QVNGSLSDSVVNGTSTNGIGVQINGSLKNSRINGISANGSGVKIDGESTL DNATLNGNSTEGKGVDLAANLSGNHGSVVHGDTVHGTGIDVGKDVTLSGG GTDEPLTVSGNASGEKGTGVQLGGNNTLDNTTLSGNATDGHGVEINSRLI NNGNTTINGKTSDDGHGVHINGAISGGEINGHSDNSHGVFLDESALLNDI VIGGGTGSYKLPVFIALPETIGERVTLNGKPIDKTQPEGSKAREGDNLTR GKYTPLPPATDPELPPASTDEEKNTKQTSTLTPSQKREDPDMLIMARNHI LSTLEGRDLSSSVVTESEQSAAGVTGIMVCLPLSETSEHEPCDTYILDKG QPHLPMMVKK >YPO3426 hofB, putative type II secretion system protein MAEFIVSSFETISDELHLLCRRYRAVALTLDGKSLSIASAQTVDEALLTA LRFTCGRQVRVEYWPEAKIEQSLYLGSPTKNNLNSSINNGLNSALLSQKG GDPSRVKPHNQQQQTIDDTVFDNESDTPVIQFITQTLSLAIQKRASDIHF EPYQHHYRVRLRIDGVLHEFTPPEAEWAARISSCLKVMAKLNIAERRLPQ DGQLTLPFGDSHYSMRIATLPTQYGEKVVLRILQIQQQTTLEKLGMTDAA LKQLTQALSAPQGLILVTGPTGSGKTITLYCSLARLNQTQRNICSVEDPI EIPVNGINQTQVNSKIGLDFSRILRAILRQDPDVIMVGEIRDNETASIAV NAAQTGHLVLSTLHTNSTAETLIRMAQMGIERHLIASSLKLVIAQRLVRR LCLHCRQAASHPFIPPAHIRSGPIQHYLAVGCEHCCTGYYGRTGIYEMLS VTPQIQQAILNNASPVKLVQIAQKQEQTALLCSGLALIEKGITTLSEINR VVGFVAETEVTS >YPO3427 hofC, putative type II secretion system protein MSRHRLFNWTALNKTGELQTGMLLATERNSVYEHIIQHGLQPLGVKGGRR LSARYWQGERLVAMTRQLATLLQAGLPLVNSLQLLAKEADDSAWRCLLDE ISQQVAQGQSLSEVMEQYPHVFPRLYPPVVAVGELTGNLEQCCTQLVHHQ ERQQNLHKKVIKALKYPVVVCIVALVVSVIMLVMVLPEFAQIYQSFDTPL PGLTASLLWLSTFLTFYGPYLALIIAIVCIGYFYTLRKKSRWQQWEQTIL LSIPLVSTLIRGSCLSQIFQTLAITQQAGLPLSAGLDAAARSIHNYNYQQ ALRCIQKQISQGIPLYTTLNQHPLFPAICQQLIRVGEESGSQDVLLEKLA CWHQQQTQNLADNVTQMLEPLLMLIIGSIVGVLVIAMYLPIFQLGDVIG >YPO3248 hxuB, putative surface-exposed protein MRDCYCHGMLWFPLKFSLLALFSLSCSPLIATPQVLNVPNAGAISNEIRQ TTIEPLNAPEETDIKLPQLNKPTPPEGGLATERITLHRVRFEGDVSLFQP GITADNKDLQALITPWLNRSLTFNDLQAMTFAVTRFYRKKGWVAAQAILP PQTIRDGIIVVRVIAGRLDKPQINNQSSLNSHFITTVIESNSCSKKNGIF GDKDCAASPVELSRLERTALILNEIPGVEASLALKPGTQSGMTRIYADVT PGKKMMAYLAADNQGNDYSGHNRLLTGGVLNNLTGWGDQLRADLILSSSA DVFNGLLDYNFPINSYGTRAALNYSYLDYTLTGPFSVLDARGHSTTWGIN LRHPWIRTSAARIDVNAGYYQARMRDALILLPEQKRNLNAGEFGISGTFT ALPRGLSNFNLLGTAGDLALDDEYSQSINTLTHVSGNFSRFNYRVGHDQG IGSHVSFFNQFTGQMASKNLDSSQKLLLGGPLAVRAYGIGDGSVDKGTIF TTELRTRWQPDFPDWAGYGHQITVAAFFDQGWGAYYRQPIVGLSENNINI SGFGSYITFARPADYFLNLTWAHRTGQAVTRHQDNDQLWLSAYKMF >YPO3481 ibeB, probable outer membrane efflux lipoprotein MFSRILILSLPALLAGCISLDPDYQRPVAPVPATLPYSTASSSKAADIPW QETIIDPKLRQVIALALESNRDLRQAIADIEAARAQYGVQRAAQIPTVNA GVNGSRGRGLSDTSDGNNNTAISQSYGAQASVSAFELDLFGKKSSLSHAE FETYLATEEAAKTTRITLIADTATAWVTLAADQNQLLLAEETLKSAEQSL KLAQLRQKNGIASRIDVAAMETLYQSARADVAQYKTTVAQDKNALDLLVG QPVAAHLLPVTASTLPEVIKAVPVGLSSDVLLNRPDVLEAEHKLKSANAN IGAARAAFFPSVTLTASGGVSSSALSTLLSEGAGIWSLAPAITLPIFDGG ANRAALEYSQAQKTGYIAAYEKAIQTAFKEVADALARKATIQEQRAAQQA YVAAAQESVELAQKRYKQGIDTYLNMLDAQRTLYAAQTRLIAVQQIQTNN LITLYKVLGGGVSDVAKE >YPO2717 lepB, signal peptidase I MANMFALILAIATLLTGIIWCFERFKWGPARQAKIAAVNAQTAEIKAQTG CAVDNKTLAQAAKQPGWIETCASIFPVLALVFIVRSFIYEPFQIPSGSMM PTLLIGDFILVEKFAYGIKDPITQTTLIPTGKPNRGDIAVFKYPLDPRLD YIKRVVGLPGDRVIYNPISKEVTVQPSCNTGTSCDSALAITYSTSEPSEF VQTFRYSGNGESSAGFFPIPLNQAVPDGGVRLRERTESLGPVAHHILTVP GRQDPLGSYYQQPDQPLGVWVVPEGHYFMMGDNRDNSADSRFWGFVPERN LVGKATAIWMSFEKQEGEWPTGVRLSRIGGIH >YPO0476 lspA, signal peptidase II MNKPICSTGLRWLWLAVVVVILDISSKQWVMAHFALYESVPLIPFFNLTY AQNFGAAFSFLADKSGWQRWFFAGIAIGISVVLMVMMYRSTAKQRLINCA YALIIGGALGNLYDRLVHGAVNDFLDFYINNWHFPTFNLADVAICIGAAL VIFEGFLSPVEKNAVNNDE >YPO2437 marC, multiple antibiotic resistance protein MLSIFELFKAVGLGLVLLLPLANPLTTVALLLGLSGNMTREERNNQSLMA AIYVFFIMTIAFYAGQIVMSTFGISIPGLRIAGGLIVAFIGFRMLFPQQS AEDTQLEAKSQDLKKRKSINIAFVPLAMPSTAGPGTIAMIISSAATMKDQ TMFAPWVLAIAPVITFLCVSLILWGSLLSSGAIMRWVGKSGIEAISRLMG FLLVCMGVQFIINGVLELISTYQPVMA >YPO1713 ogl, oligogalacturonate lyase MAKGKQIPLTYHTYQDASTGAQVTRLTPPDVTCHRNYFYQKCFTRDGSKL LFGGAFDGPWNYYLLDLNSRVATQLTEGRGDNTFGGFLSPEDDALFYVKD GRNLMRVDLATLEENVVYQVPEEWVGYGTWVANSDCTKLVGIEIKREDWQ PLTDWKKFHEFYFTKPCCRLMRVDLKTGESAVILQENQWLGHPIYRPYDD STVAFCHEGPHDLVDARMWLINEDGSNMRKVKTHAEGESCTHEVWVPDGS ALVYVSYLKGSSDRFIYSADPVTLKNRQLTSMPACSHLMSNYDGTLMVGD GSDAPVDVQDNSGYKIENDPFLYVFNIKNGTQHRIARHDTSWQVFEGDRQ VTHPHPSFTPDDKQVLFTSDVHGKPALYMVTLPESVWQ >YPO3425 ppdD, putative prepilin peptidase dependent protein D precursor MAKHQGLTLQKGFTLIELMVAVAIIAVLSGIGIPSYQRYIQKAALTDMLQ AIVPYKMAVELCALEQSNLDSCNAGSNGIPAGQVSRYINAINIAKGVITL SGQHTLTGLTLAISPTRNSNGNLVWARTCTATDSAMTDSCKAVFRFNDKA PSNG >YPO1304 psaB, chaperone protein PsaB precursor MKNLFFSAYKKVFSYITSIVIFMVSLPYAYSQDVVVNTTKHLFTVKIGTT RVIYPSSSTKGVSVSVANPQDYPILVQTQVKDEDKTSPAPFIVTPPLFRL DAGLQGRVRIIRTGGKFPEDRETLQWLCLTGIPPKNGDAWGNTQNNPKNS SPTMDIQMSISTCIKLLFRPDKVKGDPTDSADSLTWRYKGNYLEVNNPTP FYMNFYSLRIGDEKINLSDLGSKDEIKNGSYVPPFSSRDFIIPVKNKGKA TEVFWQVINDNGGVSREFKSTVQ >YPO1305 psaC, outer membrane usher protein PsaC precursor MKKLIVQFTTITLLMSTSFLVGAQRYSFDPNLLVDGNNNTDTSLFEQGNE LPGTYLVDIILNGNKVDSTNVTFHSEKSPSGEPFLQSCLTKEQLSRYGVD VDAYPELSPALKNSQTNPCVNLAAIPQASEEFQFYNMQLVLSIPQAALRP EGEVPIERWDDGITAFLLNYMANISETQFRQNGGYRRSQYIQLYPGLNLG AWRVRNATNWSQSGDRGGKWQSAYTYATRGIYRLKSRVTLGESYTPGDFF DSIPFRGVMLGDDPNMQPSNQRDFIPVVRGIARSQAQVEIRQNGYLIYST VVPPGPFELSDVIPSKSGSDLHVRVLESNGASQAFIVPYEVPAIALRKGH LRYNLVAGQYRPANADVETPPVAQATVAYGLPWNLTAFIGEQWSRHYQAT SAGLGGLLGEYGALSSSITQATSQYHHQQPVKGQAWEVRYNKTLQASDTS FSLVNSQYSTNGFSTLSDVLQSYRQSGSGDNRDKIDENSRSRDLRNQISA VIGQSLGKFGYLNLNWSRQVYRGPIPAKNSLGIHYNLNVGNSFWALSWVQ NANENKNDRILSLSVSIPLGGHHDTYASYRMTSSNGSNDHEIGMYGQAFD SRLSWSVRQAEHYGQPNSGHNSGSLRLGWQGSYGNIAGNYYYTPSIRQLS ADVSGGAIIHRHGLTLGPQINGTSVLVEVPGVGGVTTTEDRRLKTDFRGY SIVSGLSPYQEHDIVLETADLPPDAEVAKTDTKVLPTEGAIVRASFSPQI GAKALMTITRANGQTIPFGAMASLVNQSANAAIVDEGGKAYLTGLPETGQ LLVQWGKDAGQQCRVDYQLSPAEKGDTGLYMLSGVCH >YPO0564 secA, translocase MLIKLLTKVFGSRNDRTLRRMQKVVDVINRMEPDIEKLTDTELRAKTDEF RERLAKGEVLENLIPEAFAVVREASKRVFGMRHFDVQLLGGMVLNERCIA EMRTGEGKTLTATLPAYLNALSGRGVHVVTVNDYLAQRDAENNRPLFEFL GLSIGINLPNMTAPAKRAAYAADITYGTNNEFGFDYLRDNMAFSPEERVQ RQLHYALVDEVDSILIDEARTPLIISGPAEDSSEMYIRVNKLIPKLIRQE KEDSDSFQGEGHFSVDEKSRQVHLTERGLILIEQMLVEAGIMDEGESLYS PANIMLMHHVTAALRAHVLFTRDVDYIVKDGEVIIVDEHTGRTMQGRRWS DGLHQAVEAKEGVEIQNENQTLASITFQNYFRLYEKLAGMTGTADTEAFE FSSIYKLDTIVVPTNRPMIRKDLADLVYMTEQEKIGAIIEDIRERTANGQ PVLVGTISIEKSEVVSAELTKAGIEHKVLNAKFHAMEAEIVSQAGQPGAV TIATNMAGRGTDIVLGGSWQSEIAALEDPTEEQIAAIKAAWQIRHDAVLA SGGLHIIGTERHESRRIDNQLRGRAGRQGDAGSSRFYLSMEDALMRIFAS DRVSGMMRKLGMKPGEAIEHPWVTKAIANAQRKVESRNFDIRKQLLEYDD VANDQRRAIYSQRNELLDVSDVSETINSIREDVFKTTIDSYIPTQSLEEM WDIEGLEQRLKNDFDLDMPIAKWLEDEPQLHEETLRERILQQAIETYQRK EEVVGIEMMRNFEKGVMLQTLDSLWKEHLAAMDYLRQGIHLRGYAQKDPK QEYKRESFAMFAAMLESLKYEVISVLSKVQVRMPEEVEALEVQRREEAER LARQQQLSHQTDNSALMSEEEVKVANSLERKVGRNDPCPCGSGKKYKQCH GRLQ >YPO0067 secB, export protein SecB MSEQNNTEMAFQIQRIYTKDISFEAPNAPQVFQQDWQPEVKLDLDTASSQ LAEDVYEVVLRVTVTASLGEETAFLCEVQQGGIFSVAGIEGTQLAHCLGA YCPNILFPYARECITSLVSRGTFPQLNLAPVNFDALFMNYLQQQAEGEVE GVEQRQDA >YPO3189 secD, protein export protein SecD MLNRYPLWKYLMLIVVIFVGLLYALPNLYGEDPAVQITGARGIAASETTL VQVRDVLEKDNIASKSIALENGAILARFRDPDVQLRAREALVEALGDKYV IALNLAPATPSWLAKLGAEPMKLGLDLRGGVHFLMEVDMDTALGKLQEQT MDTLRTDLREKNIPYATVRKLDNYGVEVRFRDDKARNDAISYLSSRHRDL VFSSNGSNTLKAVMSDERLREAREYAVQQNITILRNRVNQLGVAEPLVQR QGSDRIVVELPGIQDTARAKEILGATATLEFRLVNTNVDASVAASGRVPG DSEVKNTREGRPVVLYKRVILTGDHITDSTSSTDEYNQAQVNISLDSAGG STMSNFTKDNIGKPMATLFVEYKDSGKKDANGRSILVKQEEVINVATIQS RLGNSFRITGIDNPAEARQLSLLLRAGALIAPIQIVEERTIGPTLGSQNI AQGLEACLWGLAVSILFMVVYYRKFGVIASTALMANLVLIVGVMSLLPGA TLTMPGIAGIVLTLAVAVDANVLINERIKEEYRNGRTIQQAIHEGYKGAF SSIVDANITTLITAIILYAVGTGSIKGFAITTAIGVVTSMFTAIVGTRAI VNLLYGGKRINKLSI >YPO3753 secE, translocase MSANTEAPGSGRGLETAKWLIVAVLLVVAIVGNYYYREYSLPLRALAVVV IIAVAGAVALMTAKGKATVAFAREARTEVRKVIWPTRQETLHTTLIVAAV TAVMSLILWGLDGILVRLVSFITGLRF >YPO3188 secF, protein export protein SecF MAQDYTVEQLNYGRKVYDFMRWDYVAFGVSLLLLVASIVVMSTKGFNWGL DFTGGTVIEINLENPADLDQLRDTLQNAGFESPILQNFGSSRDVMVRMPP ATGTAGQELGNKIISVINESVDKNASVKRIEFVGPSVGSDLAQAGALALL VALLSILVYVGFRFEWRLALGAVISLAHDVVITMGILSLFHIEIDLTIIA SLMSVIGYSLNDSIVVSDRIRENFRKIRRGTPYEIMNVSLTQTLSRTIMT SATTLMVVLMLFIFGGAMLQGFSLTMLIGVTIGTVSSIYVASALALKLGM KREHMLQPKVEKEGADQPSILP >YPO3499 secG, protein-export membrane protein MYEALLVFFLLISIGLVALIMLQQGKGADMGASFGAGASATLFGSNGSGN FMTRMTAVLATLFFVISLILGNMSSNQGQKSSEWENLGQPLKTEQTATPV APVKPSSDIPQ >YPO0229 secY, preprotein translocase SecY MAKQPGLDFQSAKGGLGELKRRLLFVIGALIVFRIGSFIPIPGIDATVLA KLLEQQRGTIIEMFNMFSGGALSRASIFALGIMPYISASIIIQLLTVVHP ALAEIKKEGEAGRRKISQYTRYGTLVLAIFQSIGIATGLPNMPGMQGLVI NPGFAFYFTAVVSLVTGTMFLMWLGEQITERGIGNGISIIIFAGIVAGLP PAIAHTIEQARQGDLHFLLLLLVAVLVFAVTFFVVFIERGQRRIVVNYAK RQQGRRVYAAQSTHLPLKVNMAGVIPAIFASSIILFPATIASWFGGGTGW NWLTTISMYLQPGQPLYVLLYASAIIFFCFFYTALVFNPRETADNLKKSG AFVPGIRPGEQTAKYIDKVMTRLTLIGAMYITFICLIPEFMRDAMKVPFY FGGTSLLIVVVVIMDFMAQVQTLMMSSQYESALKKANLKGYNR >YPO3720 shlB, hemolysin activator protein MIRKRTALWLVLSTGAQAETPLAIETPSSINESRQSLQNNAKEINQLVEE KRHQQITQHNTGQSELSRPAPPAPVLPEDTQCLPINGVYIQGITLLTEDD LSELSAIPEQCIHPDNINLLTRELTHIYMDKGYITARIQFIPPDADGKLG LDITEGFVEAIDSTDTGLDGETVFPNMIGKPLNITRLDQGLDQANRLPSN KVTVDILPGTLPGGSILKLHNTPSTPWHLTTSMDNYGNKNTGKWLSRNAL SFDNPLGLSDSVSINISNTVDRPQHNYSRAYSMFYSVPYGALTFSGFGSY AEYRYPMKLQFNTAKLHGETQQHGLRADYVFYRDQSQINGLSAQLTYKRA SNYLNEEKIAISSPTLTIFELGLNHLHVLPMGLFNINVSLEQGLPWLGAE RSNGPLANYQDSQFTKAKTSITSNHYFALFDDTYLFSNQFYGQYTRDRLP GVEWLSITDSSAIRGFSRNTLSADQGWYLQNTLSRRFTLGDATLTPRVGL DTGRLQQKPQGWVSAMGLSAGVSLNYQNATLDIEASRGRLLSGPSKINDP TQILARFSYRF >YPO2216 sohB, peptidase family U7 protein MELISLYGLFLAKVVTIVVAIGAVVLLVVSQGMRRQGQRGELNLVDLGEQ YKETQREMRLARMSHAEQKAWVKEFKKQEKADQKLKKQRAKSGAVAAVKP CLYVIDFKGSIGAQEVSSLREEISAILAVATAQDEVLLRLESPGGVVHGY GLAASQLARLRQRGIRLTVAVDKVAASGGYMMACVADRIICAPFAIIGSI GVVAQIPNFHRLLKKNDIDVELHTAGEFKRTLTLFGENTEQGREKFREDL NETHLLFKQFVQQQRPSLDIDAVATGEHWFGTQAKEKGLVDAIGTSDDLL IAEMDNHEVIGVRYSHRKRLIERFMGSATESVDSLLLRWWQRGEKPLL >YPO2162 sppA, protease IV MRTLWRIIAGFFKWTWRLLNFTRELILNLFLALLILIGVGIYFQFQSKPV EPVKGALLVNLSGVIVDQPAINNKLRQWGRELLGASSNRLQENSLFDIVE TIRLAKDDDNINGLVLSLSDLTGADQSSLQYIGKALREFRDTGKKIYAVG DSYNQTQYYLASFANKIYLSPQGAVDLHGFASNNLYYKSLLENLKVTTNI FRVGTYKSAVEPMIRNDMSAAAREADSRWVGGLWQNYLTTVSANRRLTPE QLFPGAAGVISGLQVAGGSQAKYALDSKLVDQLAARPEVESALVEAFGWN KKTNDFNYISIYDYQPTPAPQQGEQIAVLFANGAIIDGPQPPGNVGGDTL AAQIRQARLDPKIKAVILRVNSPGGSVSASELIRAELAALRAAHKPLVVS MGGMAASGGYWISTPANYIVASPSTLTGSIGIFGVINTFQNSLASIGVHT DGVATSPLADVSLTKALPPEFSQMMQINIENGYKTFIDLVATSRHKTPEQ VDQIAQGHVWIGLDAKSNGLVDQLGDFDDAVKKAAELAKLKTWQLNWFVD EPSLSDLILGQMSASVHAMLPAAIQTWLPAPLSAMALAVKDQHGLFNTLN DPQNRYALCLTCGDVR >YPO3778 tatA, Sec-independent protein translocase protein TatA MGSIGWAQLLIIAVIVVLLFGTNKLRTLGSDLGASIKGFKKAMGDDSQTP PTNVDKTSNDADFAKSITEKQQPVAKAEESKSHEKEQG >YPO3777 tatB, Sec-independent protein translocase protein TatB MFDIGFSELLLVLVIGLVVLGPERLPVAVRTVSGWIRTLRSLAATVQNEL AQELKLQELQDSLKKVEQAGLQNLTPELKASMDELKEAAEALKRSYHVDA GSEAPHTIHNPLVTEPEAIHDGVTPAEPATQVSALAQAPNILEAGTASVV DSVVEAAPVTTVKSVVQGEVLVKSTPVQEVGLADVMDKPVTKQQIDTIDS HGTDLSSAGPSRIHQPGGDQ >YPO3776 tatC, Sec-independent protein translocase protein TatC MAVDDTQPLISHLIELRKRLLNCIITILVVFLVLVFFANDIYNLVSAPLI KQLPAGASMIATDVASPFFTPIKLTMMVSVFVSAPMTLYQVWAFIAPALY KHERRLMVPLLISSSLLFYLGMAFAYFVVFPLAFGFFAKTAPESVLIATD ITKYLDFVMALFMAFGISFEVPIAIILLCWAGVTTPEALKKKRPYVFVGA FVVGMLLTPPDVLSQTLLAIPMYLLFEVGVFFARFYTGKQRRAATEEDEG IDSHPKAP >YPO2597 tatE, twin argininte translocase protein A MEGLSITKLLVVGILIVLLFGTSKLRTLGADLGAALKGFKKAMRNDDEVS TSVLGETKMSAETKTVAETKAASDSQAAASVERKD >YPO1124 tolB, translocation protein TolB precursor MKQAFRVALGFLVLWASVLHAEVRIEITQGVDSARPIGVVPFKWMGPGTP PEEIGAIVGADLRNSGKFNPIDAARMPQQPSTAAEVTPAAWTALGIDAVV VGQVQPSADGSYVVSYQLVDTSGSAGSILAQNQYKVTKQWLRYSAHTVSD EVFEKLTGIKGAFRTRIAYVVKTNGGKFPHELRVSDYDGYNQFVVHRSPE PLMSPAWSPDGSKIAYVTFESGKSALVIQTLANGAIRQVASFPRHNGAPA FSPDGTKLAFALSKSGSLNLYVMDLASGQISQVTDGRSNNTEPSWFPDSQ NLAYTSDQGGRPQVYKVNINGGVPQRITWEGSQNQNADVSPDGKFLVLVS SNGGAQHIAKQDLETGAVQVLTDTLLDETPSIAPNGTMVIYSSTQGLGSV LQLVSTDGRFKARLPATDGQVKFPAWSPYL >YPO0663 tolC, outer membrane channel precursor protein MQMKKLLPLLIGLSLAGFSTMSQAENLLQVYKQARDSNPDLRKAAADRDA AYEKINEVRSPLLPQLGLSAGYTHANGFRDASNSPDSNATSGSLKLTQTI FDMSKWRALTLQEKAAGIQDVTFQTSEQQLILNTATAYFNVLRAIDSLSY TEAQKQSVYRQLDQTTQRFNVGLVAITDVQNARASYDTVLAAEVAARNNL DNALESLRQITGVYYPELASLNVERLKTQRPDAVNNLLKEAEKRNLSLLS ARLSQDLAREQIKSAETGYMPTVDLTASSSITNTRYSGGTPSSQQVNNDS GQNQIGVQFSLPLYSGGATNSAVKQAQYNFVGASELLESAHRNMVQTLRS SFNNISASISSINAYQQVVISNQSSLDAMEAGYQVGTRTILDVLTATTNL YQSKQQLADARYNYLINQLNIKSALGTLNMNDLMALNAVLDKPVPTSAAA LAPENTTRQTVTTPRAQ >YPO1121 tolQ, TolQ colicin import protein MADMNILDLFLQASLFVKLIMLVLMGFSIASWAIIIQRTRILNAATRDAE AFEDKFWSGIELSRLYQESQARRDTLSGSEQIFHSGFKEFARLHRANSHA PEAVIDGASRAMRISMNRELEALETHIPFLGTVGSISPYIGLFGTVWGIM HAFISLGAVKQATLQMVAPGIAEALIATAIGLFAAIPAVMAYNRLNQHVN KLEQNYDNFMEEFIAILHRQAFASTESK >YPO1122 tolR, TolR colicin import membrane protein MARVRGRKRRELKSEINIVPLLDVLLVLLLIFMATAPIITQSVEVNLPDA TDSKTVSSDDNPPVIVEVSGVGQYTVVVDHQRMELLPSEQVVAEAQARLK TNPKTVFLIGGAKEVPYDEIIKALNMLHQAGVTSVGLMTQPI >YPO3190 yajC, preprotein translocase subunit YajC MSFFISDAVASAGAPAQGNSMTSMLIMLVVFGLIFYFMILRPQQKRAKEH KKLMDSIGKGDEVLTSGGFIGRVTKVAETGYVVIALNDTTEVMIKRDFVA AVLPKGTMKAL >YPO2796 yapC, putaive autotransporter protein MDKTLLAGAISLSLVILPVQVLAFTPNVVGITVNDEVVIHGIQNVRDGGV INNGLVSDNAAITVTNGSSAGTANNTTVGDKGWLQITGALATGTIVNQGG LLDTKTAGTVIDSQINDGGHMTLGLNSQSKGYLNIAAGAELFVTNNDPYI SDVTTHNPALPANVMIENLNVAGLVEIGPSWKGTSIVPLPLSDVLGPVLV TRINNVTLQGGDINLMAYSAGGQFNRLEIENLSGQGNFAMTTQLASNTGD FITVSQQATGQFGITVQDSGKEPQSADNLALVHINRGDAQFRLLNTGGVV DLGVYQYGLYSQESNGSTDWYLATSTEELPGTTPNVTAPMLSSAAQGVLN MAAAPRHILNAELSTLRQRQGELKADAEGTVGVWARYLTDDSRLSDNKNI AFKNTLSGMEIGADKQLGLNRGNMLIGAFTSYSSSDVKSTHDANGDIRSY GGGLYLTYLDQSGFYVDTVLKANRFNNKMNTQETRGEYNQNALTTSVESG YQWPVYANLVLEPYGKVSYSRIGSADYTLSNGMVAEVAKADSVQGELGTV LAASYSINQMTIKPYIKLAITREFTKSNAVAINNIGFDNDFSGNVGKYGV GINATVANNTAIFAEVDYLNGSKIETPVTANIGFRLRF >YPO3984 yapE, putative autotransporter protein MKTNRSTLSPCFRKTMIASLLVPLCSPLYSWAVQTASITDGSTMVISGGY DTEANNHSAVFVQGSGSTINGGSDVVIETTGVGAIGAYASEGGSLGLTGS TINTENGVAFGVLNDKGTVNLQGGTITTKGQTAYGVYSSGLGSNTDIHSS AITTSYSLTHAIYGAGGTGLTLNNTTLNTSGSGSYGIYLDGSGGSLTGAN NTINSTHATKGAGIYISAGGSNATLDNTTLNITKGAVGVNVGEGSSITMD GLIATGNITNLFKVNGNASVSNANIELAAGGVLMAQGSSASNQAVIILNN VNVISNSGSTTLVDVNKDADVTINGGAYHSKGNNAKGIWVRDNNSSLNVD NAVIITEGVNATAIENRGTAIVKNTTVITKGNNSHGLYSEQSLDATNMAI STAGIGSIGVAAAKGGNLNLNDAFIETTGNSGMVLGTFADSSISAKNITG ISTGAGAYALWVDDGSSILLEESQITTQGQGAGGIYASNTGTGSHTAYTQ VTLNNSQIHSEQGPGIWANGADINVDVKNGSQLTGGNGLLVYASSNAGAA SNVNVNGDNHAVLLGDIHAAENSNINLALNNNSVWTGAATNAKQVDIDSS SIWNLTGDADVESMHVLGQMNFISNSSDTNSRAPYDNFSTLTINSNVTGS GSFTFNVQLGDNDSPVDRLYVIGNASGDHGVQVINQGGLGALTTGDGINL ITVDGETHSGSFTMSNSVSAGAYEYFLYKIDDYRWNLQSNLINPGPGPEP EIEPEEIAYRPEVPGYIAAPWLNAFYGFTTLGSLHERRGSAEGAAEGFNQ DSWGRIRGQHNNFDAGRFSYDSNIWFMQLGHDVYQAKNAAGTQVTGGMMI TLGKQNSDTRDRARAINPDLSIDTGKIKTEAYGFGGYYTLMTEEGGYLDI VSQATLYRNNYESQHNTKHNGYGVVMSAEVGQPYPLAAGWVVEPQGQLKY QYLHLSPKNFNDSISEIGGTDYSVGQVRGGLRLFSDASEKRDIKPYLTTD VLHQLGRNPQVTVATVDIRPDFTKTFWQGGAGVTAKVNSQVDLYADAKYQ KSFDGKLDGYLGNLGVKVSF >YPO0606 yapF, putative autotransporter protein MNNHKIWRLSAVAVALLISGNSYADQTLHFAQQPHNTGDHTVIAAPEVNN FSLADLTANAEGQAVDATNAGALSLRVEPTQGDAQANGVLVTSGTFTNQA QGSITVSASSQDQHAVASGLQATDAYWSTLRNQGSIRATSNSLHGSAEVY GIQAGLAFSDAAGDHYGDHMMLSNEGVMQVSATAEQDAFASGIYTNAGNG VVNNGRLDVSAHASAGDARATGLHTLSANPGVDPDPWNPANPTHLMSNNG SLSVTASGNNATASAISTEGEGVYIYNNGTLIVDAFSESAQGGASAYGIH VLNGSATINSSGRILATATGGSQQQAYEVMADGSVVNIERYTLALGNETP WAVSNGGSIVLGNGTQGADLVLMAGQASEGFAYGKEYSLDNLAYDTTSGQ QSTVGGSIAGLYGITPDIKVIHSGSSSSSLGSAALVYAPDVSHAGVSALA QRSSMEQASNIISSQLHSQLVSNAGCNQKLESADSCVFITPYAGEYRRDP VTSGYSGQRYGVLLGQNQHFGDFQLGWHGGYESASTDFNGTSVGRKEEIN TLMLGVQGGMKLSESLFIAATSTWFSSDTDYSDSNTYYGVGSQSGSYDSS GLYTDVSVGNSWQLNRNYAMTPMVGLTHIWQQRDGYTVSSNNKNYDLIDT RYSSYSDHAVALHAGVRLDGRYPLTNETLLKPFFNVGFQQMLYGDEITID QSIPNSPVVGVSTKDKTTQGTFDLGMALVSDNGVSASLQLSGMVNSDRQD FTGWANLGWAF >YPO1004 yapH, putative autotransporter protein MNTIFKVIWNASLNVWVVVSELAKGRIKTKSSRNLISEGVLPKFEQSMVS KLFRKNLLALSLGSIVFLSTGPVFAADITVSTQAELSAALSNGTYDKIIL GADITLIGSLTVNMTSNQVVIDGQGKFGLTVNNTTNYGLVVSSGSGTLTL QNMSKIDSANYYSMVVLNGANTAVNVIYNNIDFLGSSQLIYMGAYGAATN SIMTFGDILNDVVVNDRAQEIGEVNKLAFTGRFHVTHTGSSVTSFVSTGG ANNTSTMDFASGADVKIDRTGSTGDLTSTGVNAFAYTFADGASFELIANQ NVFSGTTTNRGLEIGSYNSIDGFGSGVKIVLQSRSDGSIISGNGIDNATT NAAGINNNASGDANVIYNLGTGSILKATNTGILATKNANNASDIYIRSAG DITAATGISATHNGTGTVKIKNDGTITSTTAGIAISSASIKEISVDNTDG TITATAGTGVNVLASAILNLFGGTINTSATANGITFAGTEGGHTLTDLTI NLLGTGIALSNVAGVNLTLSNVTLNTLNGTALNSLTGLTLVDSLNGRNTI NIEGAGIGIAATNTELNTFDAEALDINVNGAGIGIQATGGGVNLSASNLI INVANTLGTALQITDGIDNTTTIGNEIQLNAENATAINFLGSSSKTLNNN GTIKGSVIFAGVADHIINNNGTLDGTLTTGAGNDTLVLDSSSQSNDVINL GDGNNSVTIQNGATVSSIITGNGNDTFTINGMSVGSTYLGSLDAGTGLNT LNFNASTDELAAATSLQGFTNINLVDSHITLVSDDNIGSGMVNIDSSSEL LFGSTFDGILHATLGAGTGSAIVNNSANVSLEQASMFAGTWQVNQGGALT ASNSNQLGSAKIGLDGTLNLDNIALFNHVLTGNGTLNVAKNLATTAFDFG STVGGAFSGIVNLTKTTFALSADNAAALASATLKLSDDSVTTVGTTDRTL HGLDLSGGTLIFDGAVPQSQTSGVVTVTDLALNSGTVNITGSGSWDNTDP LATNVSILEQDRAGSTLELINATNVTGDIDALDLLVNGTAITSGTQGVQS AIQQGGSTVANAIHNYGLASSNSNGDSGLYVNYTLSALELLADGADALLL ATESGLTANRVLNAELFGVGGLVVDAQNGALTLANGSNRYEGTTTVTAGE LILGANGAFGQTSLLDIASGASANINGYSQTVGAVTNVGTVTLGSGGVLT SGLLTNGGILDLTGGALNLTAGGASTVAGGLTGAGTLNINGGNLSVSAAN SGLSGQTHIADVASVTLTDTGTLGTSAVEVLGTLNLNGANAAMTNVLSGD GTINTNAAVTLSGNNSFSGAHQIGTDGELTVGQASNLGASSATVNLGTLT SHLILNGVSESIANVLSGVAGSTVDIIGGADTALTANNSGFLGQYALAGN SKLTVASTNNLGASSSVALAGAGDTLSLSGFNGTFGNSVTGSGVLQVTDD AEVTLTSSNGVSNAVTIDIADATLNLDDIALFNHVLTGNGLLNVAKNDAS TAFDFGSTVGGAFSGIVNLTNTTFALSADNAAALARATLKLSDDSVTTVG ATDRTLHGLDLNGGTLIFDGSPPQSQANGVVTVTDLALNSGTISITGAGN WENEHPVTPPNVSLLEQDRGDILLELINAANVTGNANNLDLLVDGTAITS GTQGVESAIQQGGSTVANAIHNYGLTSSNGNGGSGLYVNYTLSALELLAN GANALLLATESGLTANRVLNAELFGVGGLVVDAQNGALTLANGNNRYEGT TTVTAGELILGANGAFGQTSLLNIASGASANINGYRQTVGAVTNSGAVTL GNGGVLTSGLLTNGGILDLTGGALNLAAGGSSTVAGGLTGAGTLNINGGD LAVSATNSGLSGQTHIADVASVTLTGTGTLGTSAVEVLGTLNLNGANAAM TNVLSGGGVINTNAAVTLSGNNSFSGAHQIGTDGELTVGQASNLGASSAT VNLGTLTSHLILNGVSESIANVLSGVAGSTVDIIGGADTALTANNSGFLG QYALAGNSKLTVASTNNLGASSSVALAGAGDTLSLSGFNGTFGNSVTGSG VLQVTDDAEVTLTSSNGVGNTVKVDIADATLNLNDIALFDHVLTGNGTLN VAKNLATTAFDFGSTVGGAFSGIVNLTNTTFALSADNAAALARATLKLSD DSVTTVGTTDRILHGLDLNGGTLIFDGSPPQSQANGVVTVTDLALNSGTI SITGAGNWENEHPVTPPNVSLLEQDRGDILLQLIDADNVTGNANDLELMI NGTTISAGQGVQSTVQQGGYTVANATHNYGMTSNGGSGLYVNYTLSALEL LADGANALLLATESGLTANRELNAELSGVGGLVVDAQNGALTLANGNNRY EGTTTVTAGELILGANGAFGQTSLLNIASGASANINGYRQTVGAVTNTGT VTLGNGGELTSTDTLINTGMINVTDGILNLENGGASSISGGLTGNGILNI KGGDFTISIDNNGLAGQTNISDGASVTLGNGGTIIGTGNLGSSVIDVLGD LNLVADNSLANVISGDGTINTTATVTLSGNSSFSGAHQIGTNGELTVGQA SNLGASSATVNLGTLTSHLILNGVSESIANVLSGVAGSTVDIIGGADTAL TANNSGFLGQYALAGNSKLTVASTNNLGASSSVALAGTGDTLSLSGFNGT FGNSVTGSGVLQVTDDAEVTLTSSNGVSNAVTIDIADATLNLDDIALFNH ALTGNGLLNVAKNDASTAFDFGATVGGAFTGTVNLNNSTFDLSGNNTTVL AQATLKLSSGNLTSVGNGVQNIGTLAMNGGTLLFDNIVDNAGIITSDGTI AANSINTTGGGEVRVNLPSNLAPSLDGLSVMELDEGEIIVTLATGAATGT GHELTLTDENGDPISAVTYQGVHNAGSTSAAATGSFNYGMTTGEDYDGLY VNYGLTALELLSTGSEALVLTAILANNGTQSNDLSAQITGSGDLAFASAN DGSTASLSNSTNSYTGTTWVSSGNLRLDADSALGQTSLLAMSTATHVDIN GTQQVVGELATEGGSTLDLNDGKLTVTGGGQIDGALTGGGELVLSGGLLN VSYDNAGFTGSTDIANGAVAHLSQAQGLGNGTINNNGTLHLDNTIGTLFN ALTGSDGEVLLSNNASVQLAGDNSGYSGLFTNQAGSILIANSAEHLGGSS IANSGALILDTGSVWELTNTISGTGTLVKRGSGTVKIEGDTVSAGLTTIE EGLLQLGSSAVTQTLSLEESLQERALLVSFASNMANLTSNVLITANGSLG GYGQVTGNVENYGNLIMPNALTGGDFGTFTIDGNYTGDEGMITFNTILAG DTSVTDRLVITGDTAGQSYVTVNNIGGVGARTFEGIKIIDVGGDSAGQFT LNGRAVGGAYEYFLYQGGASTPDDGNWYLRTEADDRRPEPASYTANLAAA NNMFVTSLADRMGETLYTDVFTGEQKTTSLWLRNEGSHNRSRDDSGELKT QDNRYVMQLGGDVAQWSRNAQDLWRVGVMAGYANSSSSTVAQVAGYRSTG SVDGYSVGIYGSWLADNADDTGAYVDSWVQYSWFDNRVSGQDLATEKYDS KGFTASVEGGYAFKVGESVNQSYFIQPKAQVVWMGVKADDHTETNGTVIS GDGNGNIQTRLGAKAFINPSDKAKVSGPAFKPFVEANWIHNTKDFGTTLD GVTVKQAGTANIAELKLGVDGQVNSQLNLWGNIGQQVGNKGYSETSVVLG VKYNF